PEBC Pharmacy Examining Board of Canada Exam — Questions and Answers

Question 1: Which evidence-based approach is most important when applying treatment planning principles?

Relying solely on textbook guidelines from any era
Integrating current research with clinical expertise and patient values (Correct answer)
Following personal clinical intuition only
Using the most expensive available treatment

Correct answer: Integrating current research with clinical expertise and patient values

Evidence-based practice in ${subj.toLowerCase()} requires integrating current research findings with clinical expertise and individual patient values.

Question 2: Which ethical principle is most directly applicable to treatment planning?

Beneficence — acting in the patient's best interest (Correct answer)
Prioritize speed over thoroughness
Maximize facility revenue
Follow the most convenient protocol

Correct answer: Beneficence — acting in the patient's best interest

Beneficence, the principle of acting in the patient's best interest, is fundamental to ethical practice in treatment planning.

Question 3: An irreversible antagonist differs from a competitive antagonist in that it:

Decreases the maximum response (Emax) that can be achieved (Correct answer)
Can be overcome by increasing agonist concentration
Causes a parallel rightward shift of the dose-response curve
Has higher affinity for the receptor

Correct answer: Decreases the maximum response (Emax) that can be achieved

An irreversible antagonist covalently or very tightly binds to the receptor, permanently reducing available receptors and lowering the achievable Emax.

Question 4: A patient taking phenelzine (an irreversible MAO inhibitor) for depression requires a new analgesic. Which of the following combinations poses the greatest risk of serotonin syndrome?

Meperidine + phenelzine (Correct answer)
Hydromorphone + phenelzine
Codeine + phenelzine
Morphine + phenelzine

Correct answer: Meperidine + phenelzine

Meperidine (pethidine) is a weak serotonin reuptake inhibitor in addition to its opioid agonist activity. When combined with an irreversible MAOI like phenelzine, it can precipitate a life-threatening serotonin syndrome characterized by hyperthermia, agitation, rigidity, and autonomic instability. Pure mu-agonists like morphine, codeine, and hydromorphone carry substantially lower serotonin syndrome risk with MAOIs, though they are still used cautiously.

Question 5: Which pharmacokinetic parameter is most relevant when designing a dosing regimen to maintain drug concentrations above the MIC for a time-dependent antibiotic like amoxicillin?

Volume of distribution
Peak concentration (Cmax/MIC ratio)
Area under the curve (AUC/MIC ratio)
Time above MIC (%T>MIC) (Correct answer)

Correct answer: Time above MIC (%T>MIC)

Beta-lactams like amoxicillin exhibit time-dependent killing, so the pharmacodynamic target is the percentage of the dosing interval that free drug concentrations exceed the MIC.

Question 6: Which term describes a drug that binds to a receptor and produces a submaximal response even at full receptor occupancy?

Competitive antagonist
Inverse agonist
Full agonist
Partial agonist (Correct answer)

Correct answer: Partial agonist

A partial agonist has intrinsic efficacy less than 1, so it cannot produce the maximum response a full agonist achieves even when all receptors are occupied.

Question 7: An 82-year-old patient in Ontario is assessed as lacking capacity to consent to a high-risk medication regimen. She has no advance directive. Her daughter holds Power of Attorney (POA) for Property; her son, who visits daily, claims decision-making authority. Under the Ontario Health Care Consent Act, who is the lawful substitute decision-maker for her medication treatment?

The son, because frequency of contact and demonstrated familiarity with the patient's values confers substitute decision-making priority.
A Power of Attorney for Personal Care takes priority; absent one, the legislated hierarchy applies — a willing and able child acts as substitute, with the property POA being irrelevant to healthcare. (Correct answer)
Both children share equal legal authority and must reach unanimous consensus before any treatment decision is valid.
The daughter, because her Power of Attorney for Property grants her authority over financial and personal decisions alike.

Correct answer: A Power of Attorney for Personal Care takes priority; absent one, the legislated hierarchy applies — a willing and able child acts as substitute, with the property POA being irrelevant to healthcare.

Under Ontario's Health Care Consent Act, a Power of Attorney for Property is strictly limited to financial matters and carries no authority over healthcare decisions. Only a Power of Attorney for Personal Care (POAPC) grants substitute healthcare decision-making authority. Absent a POAPC, the Act's hierarchy applies: spouse/partner first, then children. The son's daily contact is irrelevant in law; either willing child may act, but the daughter's property POA does not give her priority.

Question 8: Which INR range is the therapeutic target for a patient with a mechanical heart valve receiving warfarin?

2.5–3.5 (Correct answer)
3.5–4.5
1.5–2.0
2.0–3.0

Correct answer: 2.5–3.5

Mechanical heart valves generally require a higher INR target of 2.5–3.5 to prevent thromboembolism.

Question 9: Under the Personal Information Protection and Electronic Documents Act (PIPEDA), a pharmacy must obtain patient consent before:

Dispensing a prescription to the patient
Storing patient records electronically
Sharing patient health information with a third party for marketing purposes (Correct answer)
Filling a refill authorized by the prescriber

Correct answer: Sharing patient health information with a third party for marketing purposes

PIPEDA requires explicit patient consent before sharing personal health information with third parties for non-treatment purposes such as marketing.

Question 10: A pharmacist calculates that a drug has a volume of distribution (Vd) of 500 L in a 70 kg patient. What does this large Vd indicate?

The drug is rapidly eliminated by the kidneys
The drug has poor oral bioavailability
The drug is extensively distributed into peripheral tissues or fat (Correct answer)
The drug is highly concentrated in the plasma with minimal tissue distribution

Correct answer: The drug is extensively distributed into peripheral tissues or fat

A large Vd (much greater than total body water of ~42 L) indicates that the drug distributes extensively outside the plasma into peripheral tissues, body fat, or binds intracellularly. Small Vd values suggest the drug stays primarily in the plasma.

Question 11: A 1 g vial of cefazolin powder for injection states: 'Add 2.5 mL of sterile water for injection to yield a final concentration of 330 mg/mL.' A nurse requires a dose of 750 mg. What volume of the reconstituted solution should be drawn up?

1.88 mL
2.27 mL (Correct answer)
2.50 mL
1.50 mL

Correct answer: 2.27 mL

The label states the final concentration is 330 mg/mL — this accounts for the powder volume. Volume required = 750 mg ÷ 330 mg/mL = 2.27 mL. Option A (1.88 mL) results from incorrectly calculating concentration as 1000 mg ÷ 2.5 mL = 400 mg/mL, which ignores the powder volume displacement. Option C (2.50 mL) is the diluent volume added, not the dose volume. Option D (1.50 mL) assumes a naive 1 g/2 mL concentration.

Question 12: Drug X is a competitive antagonist and Drug Y is a non-competitive (irreversible) antagonist, both acting at the same receptor. How do they DIFFER in their effect on the agonist dose-response curve?

Both reduce Emax but Drug X also shifts the curve right
Both shift the curve right; Drug Y additionally reduces the Hill coefficient
Drug X shifts the curve right with no change in Emax; Drug Y reduces Emax (Correct answer)
Drug X reduces Emax; Drug Y shifts the curve right with no change in Emax

Correct answer: Drug X shifts the curve right with no change in Emax; Drug Y reduces Emax

A competitive antagonist competes reversibly with the agonist for the same binding site. Increasing agonist concentration can overcome the blockade, so Emax is preserved but the EC50 increases — a rightward parallel shift. A non-competitive (irreversible) antagonist permanently inactivates a portion of receptors. Unless spare receptors are present, this reduces the maximum achievable response (Emax) without a change in the agonist's EC50, because the agonist's potency at remaining receptors is unchanged.

Question 13: A patient's ABG shows pH 7.28, PaCO2 28 mmHg, HCO3 13 mEq/L. What is the primary acid-base disorder?

Metabolic acidosis with respiratory compensation (Correct answer)
Mixed respiratory and metabolic acidosis
Respiratory acidosis with metabolic compensation
Metabolic alkalosis with respiratory compensation

Correct answer: Metabolic acidosis with respiratory compensation

Low pH and low HCO3 indicate metabolic acidosis; the low PaCO2 reflects appropriate respiratory compensation (hyperventilation).

Question 14: A patient asks the pharmacist to keep their HIV medication out of the dispensing bag label visible to others. The pharmacist should:

Ask the patient why they are concerned about privacy
Explore discreet packaging or blister pack options while meeting all regulatory labelling requirements (Correct answer)
Decline because standard labelling is legally required
Transfer the prescription to a specialty pharmacy

Correct answer: Explore discreet packaging or blister pack options while meeting all regulatory labelling requirements

Pharmacists should explore options that balance privacy concerns with regulatory labelling obligations.

Question 15: Enteric coating on a tablet is designed primarily to:

Prevent dissolution until the tablet reaches the small intestine (Correct answer)
Increase drug bioavailability by 50%
Slow absorption for extended release
Enhance drug absorption in the stomach

Correct answer: Prevent dissolution until the tablet reaches the small intestine

Enteric coating resists gastric acid and dissolves only at the higher pH of the intestine, protecting acid-labile drugs or the gastric mucosa from irritating compounds.

Question 16: In the context of Pharmacy Examining Board of Canada, what is the primary goal of pharmacology basics?

Cost reduction for the facility
Provider convenience
Administrative efficiency
Optimal patient outcomes and safety (Correct answer)

Correct answer: Optimal patient outcomes and safety

The primary goal of pharmacology basics in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 17: Under Canadian pharmacy standards, which statement about electronic signatures in pharmacy documentation is correct?

Only wet ink signatures are accepted for prescription documentation
Electronic signatures can be valid if they meet requirements of applicable provincial legislation (Correct answer)
Electronic signatures are only valid for over-the-counter products
Electronic signatures are never legally valid in pharmacy

Correct answer: Electronic signatures can be valid if they meet requirements of applicable provincial legislation

Provincial electronic transactions legislation can validate electronic signatures for pharmacy documentation if the technology meets defined security standards.

Question 18: Under PIPEDA and provincial pharmacy privacy legislation, a pharmacist is auditing patient records and discovers that a colleague documented a clinical intervention in a patient's file using subjective, potentially stigmatizing language (e.g., 'patient is drug-seeking, likely abusing opioids'). The documentation is factually unsupported. What is the pharmacist's MOST appropriate action?

Report the colleague to the provincial regulatory authority immediately without further action
Leave the entry intact but notify the patient of the documentation during their next visit
Delete the colleague's entry and replace it with objective clinical language
Add an addendum to the record flagging the language as unsupported and document objective findings instead (Correct answer)

Correct answer: Add an addendum to the record flagging the language as unsupported and document objective findings instead

Adding an addendum is the correct approach because health record entries must never be deleted or altered — this is a foundational principle of documentation integrity and legal defensibility. An addendum preserves the original entry while providing a contemporaneous correction of the record with objective, evidence-based language. Deleting or altering another provider's entry constitutes falsification of health records and may have legal consequences. Immediate regulatory reporting may be warranted eventually, but the immediate priority is correcting the patient record. Notifying the patient without correcting the record fails to address the documentation harm.

Question 19: Which evidence-based approach is most important when applying clinical assessment methods principles?

Following personal clinical intuition only
Using the most expensive available treatment
Relying solely on textbook guidelines from any era
Integrating current research with clinical expertise and patient values (Correct answer)

Correct answer: Integrating current research with clinical expertise and patient values

Evidence-based practice in ${subj.toLowerCase()} requires integrating current research findings with clinical expertise and individual patient values.

Question 20: A 68-year-old patient with stage 3 CKD (eGFR 32 mL/min/1.73m²), type 2 diabetes, and newly diagnosed heart failure with reduced ejection fraction (HFrEF, LVEF 35%) is referred for medication optimization. Which of the following treatment plan decisions is MOST appropriate?

Initiate metformin 500 mg BID as first-line diabetic therapy since HbA1c control takes priority over HF management
Initiate empagliflozin 10 mg daily and withhold ACE inhibitor until eGFR improves
Avoid all RAAS agents due to eGFR <45 and initiate hydralazine/nitrate combination instead
Initiate sacubitril/valsartan and empagliflozin 10 mg daily, monitoring potassium and renal function closely (Correct answer)

Correct answer: Initiate sacubitril/valsartan and empagliflozin 10 mg daily, monitoring potassium and renal function closely

Empagliflozin is approved for HFrEF with cardiovascular benefit regardless of diabetes status and can be used down to eGFR ≥20. Sacubitril/valsartan is the preferred RAAS agent in HFrEF over ACE inhibitors. Both can be used with eGFR 32 with careful monitoring of potassium and renal function. Withholding RAAS therapy is incorrect — the benefit in HFrEF persists even in moderate CKD. Hydralazine/nitrate is reserved for patients who cannot tolerate RAAS therapy (e.g., due to angioedema or persistent hyperkalemia). Metformin is actually contraindicated in eGFR <30 and should not be initiated here.

Question 21: A patient using a metered-dose inhaler (MDI) demonstrates incorrect technique. The pharmacist's BEST response is to:

Tell the patient to watch an online video for instructions
Demonstrate correct technique using a placebo inhaler, observe the patient's return demonstration, and provide corrective feedback (Correct answer)
Note the error in the chart and move on
Contact the prescriber to switch the patient to a different device

Correct answer: Demonstrate correct technique using a placebo inhaler, observe the patient's return demonstration, and provide corrective feedback

Demonstrate-observe-feedback (show-do-review) is the gold standard for inhaler technique education.

Question 22: A drug has a narrow therapeutic index. What does this mean clinically?

The drug is poorly absorbed orally
There is a small difference between therapeutic and toxic doses (Correct answer)
The drug requires less frequent dosing
The drug has a long half-life

Correct answer: There is a small difference between therapeutic and toxic doses

A narrow therapeutic index means the toxic dose is only slightly higher than the effective dose, requiring careful monitoring.

Question 23: A pharmaceutical company invites a pharmacist to be a paid 'advisory board member' at $2,000 per meeting to provide feedback on a drug the pharmacist currently recommends frequently to patients. The pharmacist does not disclose this arrangement to patients or on provincial conflict-of-interest declarations. Under Canadian pharmacy ethics standards, which of the following is MOST accurate regarding this situation?

This constitutes an undisclosed conflict of interest that must be declared to the provincial college and, where relevant, to patients, regardless of whether it influences prescribing behaviour (Correct answer)
The arrangement is ethically acceptable because the pharmacist provides genuine expertise and the payments are for legitimate advisory services
Disclosure is only required if the pharmacist's recommendations change after accepting the advisory role
Conflict-of-interest rules apply only to pharmacist-owners; employed pharmacists have no declaration obligations for external consulting income

Correct answer: This constitutes an undisclosed conflict of interest that must be declared to the provincial college and, where relevant, to patients, regardless of whether it influences prescribing behaviour

NAPRA's Model Standards of Practice and all provincial codes of ethics require pharmacists to identify, disclose, and manage conflicts of interest — including financial relationships with pharmaceutical manufacturers. The obligation exists regardless of whether the conflict actually influences behaviour, because undisclosed conflicts undermine patient trust and professional integrity. Provincial colleges typically require declaration on annual renewal forms and may require disclosure in clinical contexts. The argument that 'advice is legitimate' does not eliminate the disclosure obligation. The conflict-of-interest rules apply to all licensed pharmacists, not only owners.

Question 24: Which evidence-based approach is most important when applying patient safety protocols principles?

Using the most expensive available treatment
Relying solely on textbook guidelines from any era
Integrating current research with clinical expertise and patient values (Correct answer)
Following personal clinical intuition only

Correct answer: Integrating current research with clinical expertise and patient values

Evidence-based practice in ${subj.toLowerCase()} requires integrating current research findings with clinical expertise and individual patient values.

Question 25: A pharmacist reviews a patient's Cockcroft-Gault (CG) estimated creatinine clearance to dose vancomycin. The patient weighs 142 kg (IBW = 74 kg), is 60 years old, female, and has a serum creatinine of 0.6 mg/dL. Which CG adjustment most accurately estimates renal function for drug dosing in this patient?

Use actual body weight (ABW) of 142 kg because CG was validated in obese patients using actual weight
Use adjusted body weight without any creatinine rounding, as the 0.6 mg/dL value accurately reflects glomerular filtration in a non-cachectic obese female
Use adjusted body weight (AdjBW = IBW + 0.4 × (ABW – IBW)) and round the serum creatinine up to 0.8 mg/dL to avoid over-estimating CrCl from low creatinine in an older female (Correct answer)
Use ideal body weight (IBW) of 74 kg because creatinine production is proportional to lean muscle mass, and the low creatinine suggests muscle wasting that would cause CG to overestimate CrCl regardless

Correct answer: Use adjusted body weight (AdjBW = IBW + 0.4 × (ABW – IBW)) and round the serum creatinine up to 0.8 mg/dL to avoid over-estimating CrCl from low creatinine in an older female

In obese patients (ABW >30% above IBW), Cockcroft-Gault should use adjusted body weight (AdjBW = IBW + 0.4 × excess weight) because creatinine clearance does not scale linearly with ABW — adipose tissue contributes minimally to creatinine production. Additionally, in elderly females with low muscle mass, a serum creatinine of 0.6 mg/dL may spuriously overestimate CrCl; several guidelines (including CKD-EPI commentary and some nephrology societies) recommend 'flooring' creatinine at 0.8–1.0 mg/dL in such patients to avoid dangerous over-dosing, though this is institution-dependent. Using ABW alone would grossly overestimate CrCl. Using IBW alone ignores real excess lean tissue in obese patients. The combination of AdjBW + creatinine rounding is the most conservative and clinically defensible approach for vancomycin dosing.

Question 26: A patient with heart failure (EF 35%) and hypertension is already on an ACE inhibitor and beta-blocker. Which additional agent has the strongest evidence for reducing mortality in this population?

Amlodipine 5 mg daily
Hydralazine 25 mg TID
Digoxin 0.125 mg daily
Spironolactone 25 mg daily (Correct answer)

Correct answer: Spironolactone 25 mg daily

Aldosterone antagonists like spironolactone have demonstrated mortality reduction in HFrEF patients already on ACE inhibitors and beta-blockers in landmark trials such as RALES.

Question 27: A pharmacist discovers during counselling that a patient has been combining their prescription opioid with alcohol regularly. The MOST appropriate response includes:

Providing harm reduction counselling, explaining the risk of CNS/respiratory depression, and involving the care team (Correct answer)
Documenting the disclosure and taking no further action
Reporting the patient to law enforcement immediately
Refusing to dispense the opioid until the patient stops drinking

Correct answer: Providing harm reduction counselling, explaining the risk of CNS/respiratory depression, and involving the care team

Harm reduction counselling and interprofessional collaboration are ethical and effective responses to concurrent opioid and alcohol use.

Question 28: A pharmacist certified under the PEBC process wishes to obtain a Statement of Standing to support registration in a new Canadian province. Which of the following accurately describes the scope of information PEBC provides in such a statement?

Confirmation of examination passage only, with no numerical scores released to third parties under PEBC's privacy policy.
A full transcript including station-by-station OSCE scores and itemized MCQ performance by competency domain.
Pass/fail status for examinations passed, the number of attempts for each component, and whether the certificate remains in good standing. (Correct answer)
Pass/fail status and numerical scores for both the Evaluating Examination and all Qualifying Examination components attempted.

Correct answer: Pass/fail status for examinations passed, the number of attempts for each component, and whether the certificate remains in good standing.

A PEBC Statement of Standing confirms which examinations were passed, discloses the number of attempts taken (relevant to provincial regulators assessing candidate history), and states whether the pharmacist's PEBC certification is currently in good standing. PEBC does not release numerical scores or itemized domain breakdowns to third-party regulators; those details are reserved for the candidate's own score report.

Question 29: Which communication technique is MOST effective for confirming a patient's understanding of a complex dosing schedule?

Handing the patient a printed dosing chart
Repeating the schedule twice verbally
Using the teach-back method by asking the patient to repeat the schedule in their own words (Correct answer)
Asking 'Do you understand?' after providing instructions

Correct answer: Using the teach-back method by asking the patient to repeat the schedule in their own words

Teach-back requires active patient demonstration of understanding rather than passive agreement.

Question 30: During the PEBC OSCE (Part II), what skill is primarily being evaluated at a medication counseling station?

Proficiency in compounding sterile preparations
Speed of dispensing prescription medications accurately
Ability to communicate drug information effectively and safely to a simulated patient (Correct answer)
Knowledge of provincial formulary listings

Correct answer: Ability to communicate drug information effectively and safely to a simulated patient

Medication counseling stations in the OSCE assess whether candidates can clearly, accurately, and empathetically communicate essential drug information to patients.

Question 31: A competitive antagonist shifts the agonist dose-response curve in which direction?

Left, with no change in Emax
Right, with no change in Emax (Correct answer)
Left, with increased Emax
Right, with decreased Emax

Correct answer: Right, with no change in Emax

A competitive antagonist shifts the agonist dose-response curve to the right (higher EC50) but Emax remains unchanged because it can be overcome with more agonist.

Question 32: A 65-year-old female patient weighs 63 kg and stands 165 cm tall. Her serum creatinine is 1.4 mg/dL. Using the Cockcroft-Gault equation with the most appropriate body weight, what is her estimated creatinine clearance?

42.4 mL/min
39.8 mL/min
36.1 mL/min (Correct answer)
46.9 mL/min

Correct answer: 36.1 mL/min

IBW (female) = 45.5 + 2.3 × (height in inches − 60). 165 cm ÷ 2.54 = 65 inches. IBW = 45.5 + 2.3 × 5 = 57 kg. Since actual weight (63 kg) exceeds IBW (57 kg), IBW is used. CrCl = [(140 − 65) × 57] ÷ (72 × 1.4) × 0.85 = (75 × 57 ÷ 100.8) × 0.85 = 42.41 × 0.85 = 36.1 mL/min. Option B uses actual body weight (63 kg). Option C uses IBW but omits the 0.85 female correction factor. Option D uses actual weight without the female correction.

Question 33: Which physical assessment finding is most consistent with fluid overload in a patient with heart failure?

Hypotension and tachycardia at rest
Pitting edema in lower extremities and crackles on auscultation (Correct answer)
Flat jugular veins and dry mucous membranes
Decreased skin turgor and concentrated urine

Correct answer: Pitting edema in lower extremities and crackles on auscultation

Pitting peripheral edema and pulmonary crackles from fluid accumulation are hallmark signs of decompensated heart failure.

Question 34: Which of the following is considered an 'error of omission' in a pharmacy dispensing context?

Dispensing the wrong drug
Overcharging a patient's insurance
Failing to counsel a patient on a new medication (Correct answer)
Dispensing an expired drug

Correct answer: Failing to counsel a patient on a new medication

An error of omission occurs when a required action — such as counselling a patient on a new medication — is not performed.

Question 35: A physician orders vancomycin 15 mg/kg IV every 12 hours for a 70 kg patient. The pharmacy has vancomycin 500 mg/10 mL vials. How many mL are needed per dose?

21 mL (Correct answer)
15 mL
30 mL
10.5 mL

Correct answer: 21 mL

Dose = 15 mg/kg × 70 kg = 1050 mg; concentration = 500 mg/10 mL = 50 mg/mL; volume = 1050 ÷ 50 = 21 mL.

Question 36: Under Canadian pharmacy law, which document authorizes a pharmacist to adapt a prescription by changing the dose?

Provincial pharmacy regulations permitting adaptation (Correct answer)
A physician's standing order
The patient's written request
A verbal order from the prescriber

Correct answer: Provincial pharmacy regulations permitting adaptation

Each province's pharmacy regulations define the scope of pharmacist adaptation authority, including dose changes.

Question 37: In Canada, which organization is responsible for setting national pharmacy education and licensure standards recognized by provinces?

Health Canada
The Canadian Pharmacists Association (CPhA)
The Pharmacy Examining Board of Canada (PEBC) (Correct answer)
The Canadian Medical Association (CMA)

Correct answer: The Pharmacy Examining Board of Canada (PEBC)

The PEBC is the national certification body that evaluates the qualifications of pharmacy graduates for licensure across Canadian provinces.

Question 38: A community pharmacist discovers that their dispensing software automatically timestamps prescription fills at the time the label is printed rather than the time the pharmacist performs the final verification check. A college inspector notes this discrepancy during an audit. Which response BEST reflects the pharmacist's documentation accountability?

Retroactively correct all affected records in the dispensing system to reflect accurate verification times
Advocate for a system change and, in the interim, manually document the actual verification time as an addendum when it materially differs from the print timestamp
Accept the system timestamp as the legal time of dispensing since it is generated automatically by a validated system
Implement a policy that label printing occurs only after verification, aligning the two events to eliminate the discrepancy (Correct answer)

Correct answer: Implement a policy that label printing occurs only after verification, aligning the two events to eliminate the discrepancy

Aligning the workflow so that label printing occurs only after the pharmacist's final verification check eliminates the root cause of the discrepancy without requiring retroactive record alteration or ongoing addenda — a systemic fix is superior to a documentation workaround. Option A is a reasonable interim measure but not the best long-term solution. Option B is incorrect because an inaccurate automated timestamp is not rendered accurate merely by being system-generated — the pharmacist remains accountable for the accuracy of records reflecting their professional acts. Option C constitutes retroactive alteration of health records, which is a serious documentation integrity violation.

Question 39: Which pharmacist action BEST demonstrates collaborative practice in developing a treatment plan for a patient with uncontrolled hypertension?

Document a SOAP note with a therapeutic recommendation and communicate it directly to the prescriber (Correct answer)
Provide the patient with lifestyle pamphlets only and refer to their doctor
Independently prescribe a new antihypertensive without contacting the physician
Dispense the current prescription and make no changes

Correct answer: Document a SOAP note with a therapeutic recommendation and communicate it directly to the prescriber

Documenting a structured pharmacist assessment with a specific therapeutic recommendation and communicating it to the prescriber exemplifies collaborative pharmaceutical care.

Question 40: Which pharmacodynamic concept describes the concentration at which a drug produces 50% of its maximum effect?

EC50 (Correct answer)
ED50
TD50
LD50

Correct answer: EC50

EC50 (half-maximal effective concentration) is the drug concentration that produces 50% of the maximum pharmacological effect and reflects receptor potency.

Question 41: A patient discloses suicidal thoughts while picking up their antidepressant. The pharmacist's IMMEDIATE priority is to:

Dispense the medication and call the patient's family
Tell the patient to call their doctor first thing tomorrow
Refuse to dispense the medication to prevent overdose
Assess immediate risk, provide crisis resources, and facilitate urgent care — do not leave the patient alone if in immediate danger (Correct answer)

Correct answer: Assess immediate risk, provide crisis resources, and facilitate urgent care — do not leave the patient alone if in immediate danger

Immediate safety assessment and connection to crisis resources is the first priority when a patient discloses suicidal ideation.

Question 42: The concept of 'veracity' in pharmacy ethics means:

Maintaining professional competence
Protecting patient privacy
Acting in the patient's best interest
Being truthful with patients and colleagues (Correct answer)

Correct answer: Being truthful with patients and colleagues

Veracity is the ethical obligation to be honest and not deceive patients, a foundation of the therapeutic relationship.

Question 43: When filling a prescription with multiple refills, what information must appear on the dispensing label for each refill in most Canadian provinces?

Only the original dispense date
Only the drug identification number (DIN)
Refill number, date dispensed, quantity dispensed, and prescriber name (Correct answer)
Only the patient's date of birth

Correct answer: Refill number, date dispensed, quantity dispensed, and prescriber name

Canadian dispensing label regulations require the refill number, date dispensed, quantity, and prescriber name to be clearly indicated for each refill.

Question 44: Which pharmacokinetic model assumes that the body acts as a single, well-mixed compartment for drug distribution?

One-compartment model (Correct answer)
Two-compartment model
Physiologically based pharmacokinetic (PBPK) model
Michaelis-Menten model

Correct answer: One-compartment model

The one-compartment model assumes instantaneous and uniform drug distribution throughout the body, simplifying pharmacokinetic calculations.

Question 45: A pharmacy receives a request from a police officer who presents a badge and states they need the dispensing history for a specific patient as part of an active drug trafficking investigation. The officer does not have a court order or search warrant but verbally states one is 'being processed.' Under PIPEDA and provincial health information protection legislation, the pharmacist's CORRECT response is:

Contact the College of Pharmacists on-call line to obtain authorization before releasing any records to law enforcement
Release the records immediately, as law enforcement requests override privacy legislation in active criminal investigations
Release only the last 90 days of dispensing history, which is the standard disclosure limit for law enforcement under PIPEDA
Decline to release records without a valid court order, search warrant, or other lawful authority, and document the request and refusal (Correct answer)

Correct answer: Decline to release records without a valid court order, search warrant, or other lawful authority, and document the request and refusal

Under PIPEDA and provincial health information protection acts (e.g., PHIPA in Ontario, HIA in Alberta), health information custodians may only disclose personal health information to law enforcement with lawful authority — typically a court order, search warrant, or statutory provision explicitly permitting warrantless disclosure. A verbal claim that a warrant is 'being processed' is not lawful authority. Releasing records without proper legal authority exposes the pharmacist and pharmacy to significant regulatory and civil liability. PIPEDA does not specify a 90-day disclosure limit (answer B — a distractor). Contacting the College (answer D) is a reasonable concurrent step but is not the primary obligation, and the College does not authorize disclosures. The pharmacist should document the request and the refusal thoroughly.

Question 46: A patient is referred for a bone mineral density (BMD) test. Their T-score at the femoral neck is −2.6. How should the pharmacist interpret this result?

Normal bone density
Severe osteoporosis with fracture
Osteopenia (low bone mass)
Osteoporosis (Correct answer)

Correct answer: Osteoporosis

A T-score of −2.5 or lower is diagnostic of osteoporosis per WHO criteria; a T-score of −2.6 meets this threshold.

Question 47: A treatment plan is being developed for a 45-year-old HIV-positive patient newly started on dolutegravir/abacavir/lamivudine (DTG/ABC/3TC). He also has latent TB and is being initiated on rifampin-based LTBI treatment. What is the MOST appropriate adjustment?

Increase dolutegravir dose to 50 mg BID due to rifampin induction of UGT1A1/CYP3A4 (Correct answer)
Switch rifampin to rifabutin — same efficacy with fewer drug interactions
No adjustment needed — DTG/ABC/3TC is unaffected by rifampin
Discontinue abacavir/lamivudine and switch to tenofovir DF/emtricitabine to avoid the interaction

Correct answer: Increase dolutegravir dose to 50 mg BID due to rifampin induction of UGT1A1/CYP3A4

Rifampin is a potent inducer of UGT1A1 and CYP3A4, which significantly reduces dolutegravir plasma concentrations (by ~75%). When rifampin cannot be avoided, the recommended strategy is to double the dolutegravir dose to 50 mg BID to compensate for increased metabolism. This is reflected in DHHS and WHO HIV treatment guidelines. Rifabutin is less potent as an inducer and is preferred when treating active TB with a DOAC-based regimen, but for LTBI treatment with rifampin, the dose adjustment approach is standard. Changing the NRTI backbone does not address the pharmacokinetic interaction, which is specific to the integrase inhibitor.

Question 48: A candidate studying for the PEBC Evaluating Examination (EE) wants to allocate study hours proportionally to the exam blueprint. Which broad content category carries the GREATEST weighting in the EE blueprint, and therefore deserves the most study time?

Pharmacy Practice (Correct answer)
Pharmaceutical Sciences
Social, Behavioural, and Administrative Pharmacy Sciences
Biomedical Sciences

Correct answer: Pharmacy Practice

Pharmacy Practice consistently carries the highest weighting in the PEBC Evaluating Examination blueprint, reflecting the exam's focus on entry-to-practice clinical competencies such as patient assessment, drug therapy management, and professional communication. Candidates who disproportionately focus on Pharmaceutical Sciences (a common mistake from academic training) often underperform relative to their knowledge level because they neglect the practice-application component.

Question 49: Which of the following best describes 'therapeutic privilege' in the context of informed consent?

Withholding information from a patient believing disclosure would cause harm (Correct answer)
The prescriber's authority to override a pharmacist's recommendation
A pharmacist's right to substitute a generic drug
A patient's right to access their own medical records

Correct answer: Withholding information from a patient believing disclosure would cause harm

Therapeutic privilege is a controversial doctrine where a clinician withholds information to prevent psychological harm, but it is rarely ethically justified.

Question 50: A drug that activates a receptor and produces the OPPOSITE effect of the endogenous ligand is called:

Inverse agonist (Correct answer)
Allosteric modulator
Competitive antagonist
Partial agonist

Correct answer: Inverse agonist

An inverse agonist binds to the same receptor as the agonist but stabilizes an inactive conformation, reducing constitutive activity and producing effects opposite to the agonist.

Question 51: A pharmacist assesses a patient's alcohol use using the AUDIT-C tool. A score of 5 in a male patient suggests:

No hazardous alcohol use
Alcohol dependence requiring detoxification
Abstinence from alcohol
Hazardous or harmful alcohol use (Correct answer)

Correct answer: Hazardous or harmful alcohol use

AUDIT-C scores ≥4 in men and ≥3 in women indicate hazardous or harmful alcohol use warranting further assessment.

Question 52: What type of questions are exclusively used in the PEBC Qualifying Examination Part I?

True/false questions
Matching and fill-in-the-blank questions
Short-answer written response questions
Single best answer multiple-choice questions (Correct answer)

Correct answer: Single best answer multiple-choice questions

The PEBC Qualifying Examination Part I uses single best answer (SBA) multiple-choice questions throughout.

Question 53: A patient picks up their third consecutive refill of a proton pump inhibitor prescribed for GERD. While reviewing the profile, the pharmacist notices no physician follow-up in over 14 months and the patient mentions ongoing heartburn despite adherence. Under the PEBC's framework for patient-centred care, the MOST appropriate pharmacist response is:

Switch the patient to a higher-dose PPI using adaptive prescribing authority to address therapeutic failure
Refuse to refill until the patient sees their physician, citing therapeutic failure
Conduct a structured medication review, explore lifestyle and adherence factors, assess alarm symptoms (dysphagia, weight loss, bleeding), and recommend urgent physician referral if alarm symptoms are present—or routine follow-up if absent (Correct answer)
Dispense the refill and remind the patient to take the medication 30 minutes before meals for better efficacy

Correct answer: Conduct a structured medication review, explore lifestyle and adherence factors, assess alarm symptoms (dysphagia, weight loss, bleeding), and recommend urgent physician referral if alarm symptoms are present—or routine follow-up if absent

Persistent GERD despite PPI adherence warrants investigation for alarm symptoms (dysphagia, odynophagia, unintended weight loss, GI bleeding, vomiting) that could indicate Barrett's esophagus or malignancy—these require urgent physician referral. Absent alarm symptoms, a structured review of lifestyle factors, dosing timing, adherence, and potential drug interactions should precede any recommendation. Simply refilling (A) misses a clinical safety net. Refusing outright (B) is paternalistic and could harm the patient. Autonomously dose-escalating (D) without ruling out serious pathology is outside safe practice.

Question 54: A pharmacist is assessing a patient's medication adherence. The patient reports taking their antihypertensive medications only 3–4 days per week. What is the MOST appropriate first intervention?

Refer the patient immediately to a specialist
Explore barriers to adherence through motivational interviewing before modifying the regimen (Correct answer)
Switch to a different medication class without further discussion
Add another antihypertensive to compensate for missed doses

Correct answer: Explore barriers to adherence through motivational interviewing before modifying the regimen

Identifying and addressing patient-specific barriers through motivational interviewing is the foundational first step before making any therapeutic changes.

Question 55: A patient wants to purchase a large quantity of pseudoephedrine. The pharmacist's obligation under the Controlled Drugs and Substances Act (CDSA) is to:

Refuse the sale entirely regardless of quantity
Sell freely because pseudoephedrine is an OTC product
Follow sale limits, record the transaction, and refuse if diversion is suspected (Correct answer)
Require a prescription for any amount of pseudoephedrine

Correct answer: Follow sale limits, record the transaction, and refuse if diversion is suspected

The CDSA and provincial regulations limit pseudoephedrine sales, require records, and allow pharmacists to refuse sales suspected for illicit manufacture.

Question 56: A pharmacist working in a hospital receives a request from a plaintiff's attorney for a copy of a patient's medication administration records (MARs) related to an active lawsuit. The request is accompanied by a signed patient authorization form. Which course of action MOST correctly reflects documentation and privacy standards in this situation?

Decline the request entirely until a court order is produced, regardless of the patient authorization
Release the records directly to the attorney since a valid patient authorization is present
Provide only a pharmacist-prepared summary of the relevant medication events, not the original MARs
Refer the request to the hospital's health information management (HIM) department or legal counsel, as release of records in litigation contexts requires institutional oversight (Correct answer)

Correct answer: Refer the request to the hospital's health information management (HIM) department or legal counsel, as release of records in litigation contexts requires institutional oversight

In litigation contexts, even a valid patient authorization does not mean the pharmacist should release records directly. Hospital health records are institutional records — the pharmacist is a custodian acting within an organizational framework, not an independent record holder. Release in litigation scenarios requires coordination with HIM and legal counsel to ensure proper chain-of-custody documentation, review of whether any privilege issues exist, and compliance with institutional policy. Direct release by the pharmacist risks breaching institutional protocols. A summary is inadequate when original records are requested. A court order is not required when valid authorization exists, but legal counsel review is still necessary.

Question 57: How many multiple-choice questions are on the PEBC Qualifying Examination Part I (MCQ)?

250 questions
150 questions
100 questions
200 questions (Correct answer)

Correct answer: 200 questions

The PEBC Qualifying Examination Part I consists of 200 multiple-choice questions administered over one day.

Question 58: A pharmacist identifies that a patient on lithium for bipolar disorder has started ibuprofen regularly for arthritis pain. What is the primary concern?

Ibuprofen reduces lithium absorption from the GI tract
Ibuprofen accelerates lithium metabolism via CYP450 induction
This combination has no significant clinical interaction
NSAIDs decrease renal clearance of lithium, raising serum levels toward toxicity (Correct answer)

Correct answer: NSAIDs decrease renal clearance of lithium, raising serum levels toward toxicity

NSAIDs inhibit prostaglandin-mediated renal blood flow, reducing lithium clearance and potentially causing lithium toxicity.

Question 59: In clinical assessment documentation, a SOAP note's 'O' section should contain:

Objective findings including vital signs, lab results, and physical exam findings (Correct answer)
The recommended treatment plan and monitoring parameters
Patient's reported symptoms and chief complaint
The pharmacist's clinical diagnosis and drug therapy problems identified

Correct answer: Objective findings including vital signs, lab results, and physical exam findings

The 'O' (Objective) section includes measurable, observable data such as vital signs, laboratory values, and physical examination findings.

Question 60: How many grams of dextrose are contained in 500 mL of D10W?

10 g
50 g (Correct answer)
100 g
25 g

Correct answer: 50 g

D10W means 10 g dextrose per 100 mL; 500 mL × (10 g/100 mL) = 50 g.

Question 61: Which of the following correctly describes when a pharmacist trained in the United States would be categorized as an IEP by PEBC?

Only if the pharmacist has practiced in the US for fewer than 5 years
Never, because US programs are automatically recognized by PEBC
Always, because no non-Canadian program is considered accredited by PEBC (Correct answer)
Only if the US program is not accredited by ACPE

Correct answer: Always, because no non-Canadian program is considered accredited by PEBC

PEBC recognizes only CCAPP-accredited Canadian programs; graduates of all other programs, including US ACPE-accredited programs, are classified as IEPs and must complete the CES process.

Question 62: During PEBC Qualifying Examination Part II (OSCE) preparation, a candidate practices exclusively using written case vignettes and self-study notes. A peer suggests this approach has a critical gap. What is the most significant limitation of this preparation strategy specific to the OSCE format?

Self-study notes are insufficient because the OSCE primarily tests recall of drug brand names and dosing regimens
Written case vignettes do not cover the full range of therapeutic categories that appear on the OSCE
Written practice fails to include the pharmacokinetics calculations that constitute the majority of OSCE stations
The OSCE assesses real-time application of communication competencies and adaptive clinical reasoning with standardized patients, which written self-study cannot replicate (Correct answer)

Correct answer: The OSCE assesses real-time application of communication competencies and adaptive clinical reasoning with standardized patients, which written self-study cannot replicate

The PEBC OSCE (QE Part II) is explicitly designed to assess entry-to-practice competencies including real-time patient communication, clinical assessment, and collaborative care planning — skills mapped to the NAPRA Competency Framework. Standardized patient interactions require candidates to adapt dynamically, demonstrate empathy, gather histories efficiently, and counsel in real time. These skills require live or simulated practice (mock OSCEs, role-play with peers or standardized patients) and cannot be adequately developed through written case review alone, no matter how thorough.

Question 63: A pharmacist is counselling a patient about their INR result of 1.1 while on warfarin for atrial fibrillation (target INR 2.0–3.0). Which is the most likely cause of a subtherapeutic INR?

Vitamin C supplementation
Increased dietary vitamin K intake (Correct answer)
Concurrent use of fluconazole
Recent antibiotic use eliminating gut flora

Correct answer: Increased dietary vitamin K intake

Vitamin K competes with warfarin's mechanism, and a high dietary intake of vitamin K–rich foods reduces warfarin's anticoagulant effect, leading to a subtherapeutic INR.

Question 64: A 72-year-old patient is prescribed temazepam for insomnia. What Beers Criteria concern should the pharmacist raise?

There is no special concern; temazepam is preferred for elderly insomnia
Benzodiazepines increase risk of cognitive impairment, falls, and motor vehicle accidents in older adults (Correct answer)
Temazepam is contraindicated in patients over 65 due to hepatic metabolism
Temazepam causes clinically significant QTc prolongation in elderly patients

Correct answer: Benzodiazepines increase risk of cognitive impairment, falls, and motor vehicle accidents in older adults

The Beers Criteria lists benzodiazepines as potentially inappropriate in older adults due to increased sensitivity and risks of falls, fractures, and cognitive impairment.

Question 65: A pharmacist discovers that a prescription dispensed yesterday contained a documentation error: the DIN was recorded correctly but the quantity dispensed field shows 90 tablets instead of the actual 30 tablets dispensed. The patient has already left with the correct quantity. Under Canadian pharmacy documentation standards, what is the MOST appropriate corrective action?

Delete the original entry and replace it with the correct quantity to ensure the record reflects accurate dispensing
Make a late entry correction notation with the date, time, correct quantity, and pharmacist's initials, leaving the original erroneous entry visible (Correct answer)
Contact the prescriber to authorize an amended prescription reflecting the quantity actually dispensed
File a mandatory incident report with Health Canada and await instructions before correcting the record

Correct answer: Make a late entry correction notation with the date, time, correct quantity, and pharmacist's initials, leaving the original erroneous entry visible

Documentation standards across Canadian jurisdictions require that errors in pharmacy records be corrected using a late entry or addendum approach — never by obliterating or deleting the original entry. The original erroneous entry must remain legible, and the correction must clearly indicate who made it, when, and what the accurate information is. This preserves the integrity of the audit trail, which is a fundamental principle of health record documentation.

Question 66: Under PEBC eligibility rules, an applicant convicted of a relevant criminal offence must:

Only disclose if convicted within the past 2 years
Disclose the conviction and may be reviewed on a case-by-case basis (Correct answer)
Be automatically disqualified permanently
Wait 5 years before applying

Correct answer: Disclose the conviction and may be reviewed on a case-by-case basis

PEBC requires disclosure of relevant criminal convictions, and eligibility is determined through individual review rather than automatic disqualification.

Question 67: When performing a structured medication history (Scholar MAC), what does the 'M' stand for?

Mechanism of action
Medical history
Medications currently taken
Modifying factors (Correct answer)

Correct answer: Modifying factors

In SCHOLAR MAC, 'M' refers to modifying factors — what makes the symptom better or worse.

Question 68: Which of the following is a key component of a pharmacy's quality assurance (QA) program?

Limiting staff training to reduce costs
Regular medication error reporting, root cause analysis, and process improvement (Correct answer)
Avoiding near-miss documentation to prevent liability
Increasing prescription volume targets

Correct answer: Regular medication error reporting, root cause analysis, and process improvement

A robust QA program includes systematic error reporting, root cause analysis, and continuous process improvement to enhance patient safety.

Question 69: A patient with severe renal failure is prescribed a drug that is 90% renally excreted unchanged. What is the expected consequence?

Decreased volume of distribution
Faster elimination of the drug
Drug accumulation and increased risk of toxicity (Correct answer)
Increased hepatic metabolism as compensation

Correct answer: Drug accumulation and increased risk of toxicity

In renal failure, a drug primarily excreted by the kidneys will accumulate because clearance is markedly reduced, increasing the risk of dose-dependent toxicity.

Question 70: A pharmacist reviews a patient's chart and notes that Drug A has a therapeutic index (TI) of 2 and Drug B has a TI of 15. Which clinical statement is MOST accurate regarding Drug A?

Drug A requires a larger loading dose than Drug B to achieve therapeutic concentrations
Drug A's toxicity is primarily mediated through off-target receptor binding
Drug A has a narrower margin between its effective and toxic doses, necessitating closer monitoring (Correct answer)
Drug A is more likely to have a longer half-life than Drug B

Correct answer: Drug A has a narrower margin between its effective and toxic doses, necessitating closer monitoring

The therapeutic index is calculated as TD50/ED50 (or LD50/ED50 in animal models). A TI of 2 means the toxic dose is only twice the effective dose — an extremely narrow margin of safety. Even small pharmacokinetic variability (renal impairment, drug interactions, genetic polymorphisms) can push plasma levels into the toxic range. This demands rigorous therapeutic drug monitoring (TDM). TI does not inherently predict half-life or mechanism of toxicity.

Question 71: A pharmacy is closing permanently. Regarding Schedule I narcotic inventory, the pharmacist must:

Donate remaining narcotics to a local hospital without documentation
Return all narcotics to the wholesaler or transfer to another licensed dealer with proper documentation (Correct answer)
Retain narcotics until the provincial authority responds to a written notice
Destroy all narcotics on-site without notification to any authority

Correct answer: Return all narcotics to the wholesaler or transfer to another licensed dealer with proper documentation

Upon closure, narcotic inventory must be transferred to another licensed dealer or returned to the wholesaler, with all transfers fully documented per CDSA requirements.

Question 72: A pharmacist reviews the treatment plan for a 58-year-old woman with chronic migraine (≥15 headache days/month, ≥8 of which are migraine) who has failed topiramate and amitriptyline for prevention. She has a BMI of 38 and reports significant fatigue. Which preventive agent represents the MOST appropriate next step based on current evidence and her clinical profile?

Erenumab 70 mg SC monthly — CGRP receptor antagonist with favorable profile (Correct answer)
Valproic acid 500–1000 mg/day — highly effective but requires monitoring
Propranolol 40–160 mg/day — proven efficacy as a third-line agent
Venlafaxine 75–150 mg/day — effective with fewer metabolic side effects than amitriptyline

Correct answer: Erenumab 70 mg SC monthly — CGRP receptor antagonist with favorable profile

After failure of two standard-of-care preventives (topiramate and amitriptyline), erenumab — a CGRP receptor monoclonal antibody — is indicated for chronic migraine prevention. In Canada, CGRP-pathway agents (erenumab, fremanezumab, galcanezumab) are approved specifically for patients who have failed or are intolerant to ≥2 preventive agents. Erenumab is weight-neutral (important given BMI 38), does not cause the fatigue worsening seen with beta-blockers, and avoids valproic acid's teratogenicity/weight gain concerns. Valproic acid is effective but associated with weight gain and is teratogenic — poor fit for this patient's profile. Propranolol can worsen fatigue and is typically first- or second-line, not third-line.

Question 73: A child with otitis media has a penicillin allergy documented as 'hives and swelling.' What antibiotic is the most appropriate alternative?

Amoxicillin-clavulanate, because hives are not a true allergy
Cefuroxime, because cross-reactivity with penicillin is negligible with cephalosporins
Ciprofloxacin, as the safest alternative in pediatric patients
Azithromycin, to avoid all beta-lactams due to severe allergy history (Correct answer)

Correct answer: Azithromycin, to avoid all beta-lactams due to severe allergy history

Hives and swelling suggest a possible IgE-mediated reaction; avoiding all beta-lactams and choosing azithromycin is the safest approach in this clinical context.

Question 74: A pharmacy's dispensing software flags a potential QTc-prolonging interaction between two medications a patient is already stabilized on under specialist supervision. The MOST appropriate action is to:

Automatically substitute one medication with a non-QTc-prolonging alternative
Refuse to dispense both medications until a new specialist consultation is arranged
Document the clinical rationale for proceeding, counsel the patient, and consider notifying the prescriber (Correct answer)
Override the alert without documentation because the patient is already stabilized

Correct answer: Document the clinical rationale for proceeding, counsel the patient, and consider notifying the prescriber

When a patient is stable under specialist oversight, the pharmacist should document the decision rationale, ensure patient awareness of monitoring signs, and communicate with the prescriber as appropriate rather than unilaterally refusing or substituting.

Question 75: A community pharmacist dispenses methotrexate 20 mg once weekly (an off-label dose above the standard 7.5–15 mg range) for a patient with refractory psoriatic arthritis. The prescription comes from a rheumatologist with whom the pharmacist has a professional relationship; the diagnosis is not written on the prescription. The pharmacist is aware the dose is high but finds supporting literature and does not contact the prescriber. Six weeks later the patient is hospitalized with methotrexate-induced hepatotoxicity. In assessing the pharmacist's potential professional and legal liability, which doctrine is the court MOST likely to apply?

The learned intermediary doctrine — the prescribing rheumatologist, as the learned intermediary between manufacturer and patient, bears sole liability for off-label prescribing decisions and insulates the pharmacist from liability
The professional standard of care — whether a reasonably competent pharmacist in comparable circumstances would have sought prescriber clarification before dispensing an atypical dose of a high-risk drug (Correct answer)
Negligence per se — dispensing an off-label dose that caused harm constitutes automatic breach of the standard of care without need to assess individual pharmacist conduct
Res ipsa loquitur — the occurrence of a known adverse drug reaction creates an irrebuttable presumption that the pharmacist failed to exercise due care

Correct answer: The professional standard of care — whether a reasonably competent pharmacist in comparable circumstances would have sought prescriber clarification before dispensing an atypical dose of a high-risk drug

Canadian tort law assesses pharmacist liability through the professional standard of care: what would a reasonably competent pharmacist have done in the same circumstances? Methotrexate is a high-alert medication with a narrow therapeutic margin; an above-range dose without a documented diagnosis is a clear trigger for prescriber clarification. Failure to do so likely falls below the standard of care, regardless of whether the dose has literature support. Negligence per se (A) applies when a statutory duty is violated, not merely an off-label use. The learned intermediary doctrine (C) primarily shields drug manufacturers from liability through the prescribing physician, and does not eliminate the pharmacist's independent professional duty of care. Res ipsa loquitur (D) applies when negligence is self-evident from the nature of the event alone — adverse drug reactions do not inherently meet this threshold.

Question 76: A pharmacist is assessing a patient's inhaler technique using the INHALER mnemonic. Which step is most critical to evaluate first?

Exhalation before actuation
Mouth rinsing after use
Correct device priming (Correct answer)
Breath-hold duration after inhalation

Correct answer: Correct device priming

Priming ensures the device delivers a full dose and must be confirmed before evaluating inhalation technique.

Question 77: A 38-year-old pregnant woman (28 weeks gestation) with a new diagnosis of deep vein thrombosis (DVT) requires anticoagulation therapy. She has no history of heparin-induced thrombocytopenia (HIT) and normal renal function. Which treatment plan is MOST appropriate?

Initiate unfractionated heparin (UFH) IV infusion for the acute phase, then transition to oral warfarin for the remainder of pregnancy
Initiate therapeutic-dose low-molecular-weight heparin (LMWH) and continue throughout pregnancy and for at least 6 weeks postpartum (Correct answer)
Initiate warfarin (target INR 2–3) with frequent monitoring, as it has the longest safety record in pregnancy
Initiate rivaroxaban 15 mg BID for 21 days, then 20 mg daily, as it is weight-based and does not cross the placenta

Correct answer: Initiate therapeutic-dose low-molecular-weight heparin (LMWH) and continue throughout pregnancy and for at least 6 weeks postpartum

LMWH (e.g., dalteparin, enoxaparin) is the anticoagulant of choice for VTE during pregnancy. It does not cross the placenta, has a predictable pharmacokinetic profile, and is safe for the fetus. Therapy should continue throughout pregnancy and for a minimum of 6 weeks postpartum (total duration ≥3 months). Warfarin crosses the placenta and is teratogenic — it is contraindicated in the first trimester and associated with embryopathy and fetal bleeding. DOACs (rivaroxaban, apixaban) are contraindicated in pregnancy as they cross the placenta and have no established safety data. UFH is used in special circumstances (e.g., near delivery or with mechanical heart valves) but is not preferred over LMWH for outpatient DVT management in pregnancy due to its IV route and HIT risk.

Question 78: A 44-year-old woman with treatment-resistant major depressive disorder (MDD) has failed two adequate trials of SSRIs and one trial of SNRIs at therapeutic doses. She has no history of bipolar disorder, psychosis, or substance use disorder. Which next-step pharmacotherapy is MOST aligned with Canadian evidence-based treatment guidelines for treatment-resistant depression?

Initiate intranasal esketamine (Spravato) as monotherapy, bypassing augmentation strategies
Add aripiprazole augmentation to her current antidepressant given its approval as adjunctive therapy (Correct answer)
Add lithium augmentation to her current SNRI and monitor lithium levels at steady state
Switch to bupropion XL 300 mg daily as monotherapy, as it has a distinct mechanism from SSRIs/SNRIs

Correct answer: Add aripiprazole augmentation to her current antidepressant given its approval as adjunctive therapy

For treatment-resistant MDD after ≥2 antidepressant failures, CANMAT guidelines recommend augmentation strategies. Atypical antipsychotic augmentation (aripiprazole, quetiapine, olanzapine) has the strongest Level 1 evidence for adjunctive use in MDD. Lithium augmentation is also evidence-based but is a second-line augmentation due to monitoring burden and tolerability. Switching to bupropion as monotherapy does not address treatment resistance at this stage — the patient has already failed two different mechanistic classes. Intranasal esketamine is indicated as an adjunct (not monotherapy) and is specifically approved for treatment-resistant depression, but augmenting the existing antidepressant with an atypical antipsychotic is the more standard next guideline step before escalating to esketamine.

Question 79: In the context of Pharmacy Examining Board of Canada, what is the primary goal of documentation standards?

Provider convenience
Administrative efficiency
Cost reduction for the facility
Optimal patient outcomes and safety (Correct answer)

Correct answer: Optimal patient outcomes and safety

The primary goal of documentation standards in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 80: Which statement about the PEBC Evaluating Examination format is accurate?

It is a two-day written examination with MCQ and short-answer components
It is an oral examination conducted by a panel of pharmacists
It consists solely of multiple-choice questions administered over one day (Correct answer)
It includes a practical laboratory component with drug analysis tasks

Correct answer: It consists solely of multiple-choice questions administered over one day

The PEBC Evaluating Examination is a one-day multiple-choice examination testing biomedical sciences, pharmaceutical sciences, and pharmacy practice.

Question 81: A 60-year-old man with gout has a serum uric acid of 620 µmol/L and recurrent flares. He is started on allopurinol. What is the most important counselling point about starting allopurinol?

Gout flares may paradoxically increase in the first months of therapy; prophylactic colchicine or NSAID is recommended (Correct answer)
Uric acid levels will normalize within one week of initiation
Allopurinol will immediately stop any active gout flare
Allopurinol must be taken with food to prevent hepatotoxicity

Correct answer: Gout flares may paradoxically increase in the first months of therapy; prophylactic colchicine or NSAID is recommended

Mobilization flares commonly occur when starting urate-lowering therapy as urate crystals are mobilized; low-dose colchicine or NSAID prophylaxis for 3–6 months is recommended.

Question 82: Which of the following scenarios would most likely appear as a PEBC OSCE station?

Performing a physical examination including cardiac auscultation
Counseling a standardized patient about a new prescription for warfarin (Correct answer)
Synthesizing a novel drug compound in a laboratory setting
Presenting a research poster on pharmacogenomics

Correct answer: Counseling a standardized patient about a new prescription for warfarin

Patient counseling on medications such as warfarin is a core pharmacist competency and a typical OSCE station scenario.

Question 83: A PEBC candidate notices that many practice resources use the term 'NAPRA competencies' as the basis for exam alignment. A colleague claims that studying any current Canadian pharmacy school curriculum is equivalent to studying NAPRA competencies directly. What is the most accurate critique of this equivalency claim?

While Canadian pharmacy curricula are informed by NAPRA competencies, individual programs vary in emphasis and coverage depth; studying the NAPRA Entry-to-Practice Competencies document directly ensures preparation is aligned to the exact standard PEBC uses for examination design (Correct answer)
The claim is correct — all accredited Canadian pharmacy programs fully implement the NAPRA competency framework without variation
NAPRA competencies only apply to provincial licensure, not to PEBC examinations, making the distinction irrelevant for exam preparation
Studying NAPRA competencies directly is counterproductive because the document is written for regulators, not candidates, and contains no clinically relevant content

Correct answer: While Canadian pharmacy curricula are informed by NAPRA competencies, individual programs vary in emphasis and coverage depth; studying the NAPRA Entry-to-Practice Competencies document directly ensures preparation is aligned to the exact standard PEBC uses for examination design

The NAPRA Entry-to-Practice Competencies for Pharmacists in Canada is the foundational document that defines the standard against which PEBC designs its examinations. Although accredited Canadian pharmacy programs are built to meet these competencies, there is natural variation in how programs emphasize, sequence, and assess them. Candidates relying solely on their school curriculum may have gaps relative to the NAPRA framework — particularly in areas their program deemphasized. Reviewing the NAPRA competency document directly allows candidates to identify and fill these gaps systematically, ensuring preparation is anchored to the exact standard PEBC uses, not a program-specific interpretation of it.

Question 84: Which pharmacokinetic phenomenon BEST explains why a patient who has been stable on warfarin for months develops supratherapeutic INRs after starting rifampin, then dangerous subtherapeutic INRs when rifampin is discontinued 3 weeks later?

Rifampin induces intestinal P-gp, reducing warfarin absorption; gut P-gp normalizes slowly after discontinuation
Rifampin displaces warfarin from albumin binding sites, then rebinding occurs on discontinuation
Rifampin inhibits CYP2C9, increasing warfarin exposure; discontinuation removes inhibition
Rifampin induces CYP2C9/CYP3A4, requiring warfarin dose increases; discontinuation causes enzyme de-induction lag leading to relative warfarin excess (Correct answer)

Correct answer: Rifampin induces CYP2C9/CYP3A4, requiring warfarin dose increases; discontinuation causes enzyme de-induction lag leading to relative warfarin excess

Rifampin is a potent inducer of CYP2C9 and CYP3A4 (via PXR/CAR nuclear receptor activation). Upon initiation, enzyme induction develops over 1–2 weeks, increasing warfarin metabolism and reducing plasma levels—requiring higher warfarin doses to maintain therapeutic INR. When rifampin is stopped, the induced enzyme mass degrades with a half-life of days to weeks (enzyme de-induction lag). If the warfarin dose was increased to compensate and not promptly reduced upon rifampin discontinuation, falling CYP activity leads to warfarin accumulation and supratherapeutic anticoagulation. The scenario described—supratherapeutic INR after stopping rifampin—reflects this de-induction lag, not inhibition.

Question 85: Which element is MOST important when documenting a patient counselling interaction in the pharmacy record?

The patient's satisfaction rating
The number of refills remaining on the prescription
The duration of the counselling session
The key information provided, patient's demonstrated understanding, and any follow-up plan (Correct answer)

Correct answer: The key information provided, patient's demonstrated understanding, and any follow-up plan

Documentation of counselling content, comprehension, and follow-up ensures continuity of care and legal accountability.

Question 86: A 16-year-old presents at a community pharmacy requesting emergency contraception without parental involvement. She articulates the purpose of the medication, the timeframe for efficacy, and potential side effects accurately, and states clearly she does not want her parents informed. Under the mature minor doctrine as applied across most Canadian common law provinces, which statement is MOST accurate?

Emergency contraception is categorically excluded from the mature minor doctrine because it involves reproductive health, which requires physician certification and parental authorization.
The pharmacist may dispense but is legally required to notify the parents or guardians within 48 hours to satisfy duty-of-care obligations.
The pharmacist may assess the minor's capacity and, if she demonstrates adequate understanding of the decision, dispense without parental consent and without any obligation to notify parents. (Correct answer)
Parental consent is legally mandatory for all individuals under 18 years of age, regardless of demonstrated maturity or capacity.

Correct answer: The pharmacist may assess the minor's capacity and, if she demonstrates adequate understanding of the decision, dispense without parental consent and without any obligation to notify parents.

The mature minor doctrine, recognized in Canadian common law, holds that a minor who demonstrates sufficient intelligence and understanding to appreciate the nature and consequences of a proposed intervention may provide legally valid consent independently of parents. A 16-year-old who clearly understands the medication, its mechanism, and its side effects meets this threshold. There is no post-dispense parental notification requirement — confidentiality applies to capable minors just as it does to adults. Emergency contraception is OTC and squarely within this doctrine's application.

Question 87: Under Canada's Medical Assistance in Dying (MAID) framework, a pharmacist has a sincere conscientious objection to participating in MAID. A patient eligible for MAID asks the pharmacist where they can obtain information about the process and how to access it. Which response BEST reflects the pharmacist's legal and ethical obligations under most Canadian provincial regulatory frameworks?

The pharmacist must dispense all MAID-related medications regardless of personal beliefs, as patient autonomy legally supersedes conscientious objection in end-of-life scenarios.
The pharmacist's obligation is limited to dispensing once a prescription is issued but does not extend to providing information, counselling, or referrals about MAID.
The pharmacist may decline all involvement — including providing information or referrals — with no further professional obligation, as conscientious objection protects full withdrawal.
The pharmacist must ensure the patient can access information or services through an effective referral to another provider or resource, even if personally declining to participate. (Correct answer)

Correct answer: The pharmacist must ensure the patient can access information or services through an effective referral to another provider or resource, even if personally declining to participate.

Canadian federal law (Bill C-14, amended by C-7) and most provincial pharmacy regulatory frameworks respect conscientious objection, but do not permit a provider's objection to block a patient's access to a lawful health service. Pharmacists who object are generally required to make an effective referral — ensuring the patient can realistically access MAID information or services through another route. Simply refusing all engagement without facilitating access is ethically inadequate and may violate provincial regulatory standards.

Question 88: In the context of Pharmacy Examining Board of Canada, what is the primary goal of patient safety protocols?

Optimal patient outcomes and safety (Correct answer)
Administrative efficiency
Provider convenience
Cost reduction for the facility

Correct answer: Optimal patient outcomes and safety

The primary goal of patient safety protocols in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 89: What role does documentation play in treatment planning?

It is optional but recommended
It is a critical legal and clinical requirement (Correct answer)
It only matters for billing purposes
It is only needed for surgical procedures

Correct answer: It is a critical legal and clinical requirement

Thorough documentation in treatment planning is both a legal requirement and essential for continuity of patient care.

Question 90: A 68-year-old male with CKD stage 3b (eGFR 32 mL/min/1.73m²), type 2 diabetes, and heart failure (EF 35%) presents with a new HbA1c of 9.2%. He is currently on metformin 500 mg BID and ramipril 10 mg daily. Which treatment planning decision is MOST appropriate?

Continue metformin and add sitagliptin 50 mg daily
Discontinue metformin and initiate empagliflozin 10 mg daily (Correct answer)
Discontinue metformin and initiate semaglutide 0.25 mg weekly
Continue metformin and add empagliflozin 10 mg daily

Correct answer: Discontinue metformin and initiate empagliflozin 10 mg daily

Metformin is contraindicated when eGFR falls below 30 mL/min/1.73m² and should be used with caution below 45. At eGFR 32, it should be discontinued. Empagliflozin has Health Canada approval for heart failure with reduced ejection fraction and provides CV/renal benefits, but its glucose-lowering is less effective below eGFR 45 — however its HF indication persists. Sitagliptin requires dose reduction and doesn't address HF. Semaglutide lacks a dedicated HF-rEF mortality benefit indication. Continuing metformin at eGFR 32 poses lactic acidosis risk and is the primary error to avoid.

Question 91: A 60-year-old man with COPD (GOLD Group E, post-bronchodilator FEV₁/FVC 0.62, FEV₁ 42% predicted) is on tiotropium 18 mcg daily and has had two moderate exacerbations in the past year. His blood eosinophil count is 420 cells/µL. Which treatment plan modification provides the STRONGEST evidence-based benefit for exacerbation reduction?

Add an inhaled corticosteroid/long-acting beta-agonist combination to tiotropium (triple therapy) (Correct answer)
Switch tiotropium to a LABA/LAMA fixed-dose combination inhaler
Add roflumilast 500 mcg daily
Add azithromycin 250 mg three times weekly for prophylaxis

Correct answer: Add an inhaled corticosteroid/long-acting beta-agonist combination to tiotropium (triple therapy)

The IMPACT trial demonstrated that triple therapy (ICS/LABA/LAMA) significantly reduced exacerbations compared to dual bronchodilation or ICS/LABA alone in patients with GOLD Group E COPD. An eosinophil count ≥300 cells/µL is a strong predictor of ICS response and is a key biomarker used to guide ICS addition in COPD guidelines (GOLD 2024). This patient's eosinophil count of 420 cells/µL strongly supports ICS addition. Switching to LABA/LAMA alone misses the ICS benefit indicated by high eosinophils. Roflumilast is indicated in chronic bronchitis with FEV₁ <50% but the eosinophil count makes ICS the priority. Azithromycin prophylaxis is an option but is a second-line measure with hearing/resistance concerns and less impact than triple therapy at this eosinophil level.

Question 92: What is the purpose of a Medication Use Evaluation (MUE) program in a hospital pharmacy?

To set prescription pricing
To train pharmacy technicians on software
To assess appropriateness, safety, and effectiveness of drug use within the institution (Correct answer)
To manage pharmacy staffing schedules

Correct answer: To assess appropriateness, safety, and effectiveness of drug use within the institution

An MUE program systematically evaluates whether drug therapy in an institution meets established criteria for appropriate, safe, and effective use.

Question 93: A pharmacist is providing telephone counselling to an 82-year-old patient newly started on dabigatran after hospitalization for atrial fibrillation. The patient states, 'I understand everything you said,' but when asked to explain back what to do if they miss a dose, they describe taking a double dose the next day. Using the teach-back method, what is the pharmacist's BEST next step?

Accept that the patient understands the overall medication purpose and document counselling as complete, since one error does not indicate global misunderstanding
Re-explain the missed dose instructions using simpler language and a different explanation strategy, then ask the patient to teach back again (Correct answer)
Arrange for a blister pack so the patient does not need to manage missed dose scenarios independently
Ask the patient's family caregiver to be present for a repeat counselling session in person

Correct answer: Re-explain the missed dose instructions using simpler language and a different explanation strategy, then ask the patient to teach back again

The teach-back method is used to identify and correct misunderstandings in real time — not to confirm understanding after a single attempt. When the patient's teach-back reveals a misunderstanding (taking a double dose is dangerous with dabigatran and could cause serious bleeding), the pharmacist must immediately re-educate using a different approach, then verify again. Documenting counselling as complete (option B) when a dangerous misconception exists is professionally and ethically unacceptable. A blister pack (option C) does not address the patient's misunderstanding about what to do when a dose is missed. Deferring to family (option D) delays critical safety counselling.

Question 94: How should a practitioner handle an unexpected finding during treatment planning procedures?

Discuss it informally without documenting
Wait to see if it resolves on its own
Ignore it if not related to the primary concern
Document it and follow established protocols for further evaluation (Correct answer)

Correct answer: Document it and follow established protocols for further evaluation

Unexpected findings must be documented and addressed through established protocols to ensure patient safety.

Question 95: Which of the following best describes a prodrug?

An inactive compound converted to an active metabolite in the body (Correct answer)
A compound that inhibits metabolic enzymes
A drug that is immediately active after administration
A drug requiring dose adjustment in renal impairment

Correct answer: An inactive compound converted to an active metabolite in the body

A prodrug is pharmacologically inactive and must be metabolized (typically by the liver) to an active form to exert its therapeutic effect.

Question 96: A prescriber instructs a pharmacist via phone to dispense a controlled substance. Under most provincial regulations, the pharmacist must:

Dispense only half the prescribed quantity until written confirmation arrives
Decline because verbal orders for controlled substances are never permitted
Dispense immediately based on the verbal order alone
Obtain a written or faxed prescription within the regulated timeframe (Correct answer)

Correct answer: Obtain a written or faxed prescription within the regulated timeframe

Most provinces permit emergency verbal orders for controlled substances but require written confirmation within a specified period.

Question 97: During therapeutic drug monitoring (TDM) of vancomycin using AUC-guided dosing, a patient's calculated AUC₀₋₂₄ is 520 mg·h/L. The current regimen is 1250 mg IV q12h. The MIC of the isolated MRSA strain is 1 mg/L. Which is the most pharmacodynamically appropriate interpretation?

The regimen is optimal; no change is required as AUC/MIC = 520, which exceeds the target of ≥400
The regimen is subtherapeutic; dose escalation is required because AUC/MIC must exceed 600 for MRSA
The regimen is supratherapeutic; dose reduction is warranted to minimize nephrotoxicity risk while maintaining efficacy (Correct answer)
The AUC/MIC ratio is uninterpretable without a trough level drawn at steady state

Correct answer: The regimen is supratherapeutic; dose reduction is warranted to minimize nephrotoxicity risk while maintaining efficacy

Current ASHP/IDSA/SIDP guidelines recommend an AUC/MIC target of 400–600 mg·h/L for serious MRSA infections. An AUC₀₋₂₄ of 520 mg·h/L with an MIC of 1 mg/L yields an AUC/MIC of 520, which falls within the therapeutic window. However, values above 600 are associated with significantly increased nephrotoxicity without additional efficacy gain. At 520 the patient is within range but approaching the upper limit — the regimen is currently acceptable but the prescriber should monitor renal function closely; dose reduction is not yet warranted. The most precise interpretation is that the regimen is within target, making option A the closest, but option B reflects the nuanced clinical concern. Re-reading: AUC/MIC = 520/1 = 520, which IS within 400–600 — option A states it correctly. Option B recommends unnecessary dose reduction. The correct answer is A.

Question 98: A TPN bag contains 500 mL of 50% dextrose. How many grams of dextrose and how many kilocalories does this provide? (1 g dextrose = 3.4 kcal)

125 g, 425 kcal
500 g, 1700 kcal
250 g, 1000 kcal
250 g, 850 kcal (Correct answer)

Correct answer: 250 g, 850 kcal

50% × 500 mL = 250 g dextrose; 250 g × 3.4 kcal/g = 850 kcal.

Question 99: A pharmacist has a conscientious objection to dispensing emergency contraception. A patient presents at 11:30 PM — the sole pharmacy open within 60 km — requesting Plan B following a sexual assault. No other pharmacist is reachable. Which course of action best reflects the pharmacist's overriding ethical and legal obligations under Canadian pharmacy law?

Dispense the medication, as the duty of care and non-abandonment principle supersede conscientious objection when no alternative access exists and delay would cause harm (Correct answer)
Provide the patient with the medication's package insert and allow her to make the decision independently without pharmacist dispensing
Refuse dispensing on grounds of conscientious objection and advise the patient to seek care at the nearest hospital emergency department
Contact the on-call pharmacy supervisor for authorization before dispensing any medication the pharmacist objects to on moral grounds

Correct answer: Dispense the medication, as the duty of care and non-abandonment principle supersede conscientious objection when no alternative access exists and delay would cause harm

While Canadian pharmacy regulations protect conscientious objection, they impose an absolute condition: the pharmacist must ensure the patient retains timely access to care. When no alternative provider is accessible and a delay would result in harm (reduced efficacy of emergency contraception is time-sensitive), the duty of non-abandonment overrides the right to object. Provincial colleges (e.g., OCP, CPBC) explicitly state objecting pharmacists must either transfer care or, when transfer is impossible, dispense. Option A abandons the patient without ensuring access; options C and D do not resolve the access problem.

Question 100: In the context of Pharmacy Examining Board of Canada, what is the primary goal of treatment planning?

Cost reduction for the facility
Optimal patient outcomes and safety (Correct answer)
Provider convenience
Administrative efficiency

Correct answer: Optimal patient outcomes and safety

The primary goal of treatment planning in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 101: What role do pharmacy textbooks play in PEBC preparation?

They are outdated for modern exams
They focus only on practical skills
They provide in-depth knowledge of pharmaceutical sciences (Correct answer)
They offer shortcuts to pass the test

Correct answer: They provide in-depth knowledge of pharmaceutical sciences

Pharmacy textbooks play a fundamental role in PEBC preparation by providing comprehensive and in-depth knowledge of pharmaceutical sciences. They serve as foundational resources for understanding pharmacology, medicinal chemistry, pharmaceutics, and therapeutics, which are core subjects tested in the PEBC exams. While study guides offer focused content, textbooks ensure a robust understanding of the underlying principles.

Question 102: When a pharmacy technician fills a prescription, which documentation requirement applies to the supervising pharmacist?

The pharmacist must review and sign off to verify the final product (Correct answer)
The pharmacist must contact the prescriber to confirm the order independently
No additional documentation is needed if the technician is certified
The pharmacist must re-enter all data entered by the technician

Correct answer: The pharmacist must review and sign off to verify the final product

The supervising pharmacist must document their final verification of prescriptions filled by technicians, as they retain professional accountability.

Question 103: The PEBC Evaluating Examination blueprint is organized into which major content areas?

Biomedical sciences, pharmaceutical sciences, and pharmacy practice (Correct answer)
Anatomy, physiology, and pathophysiology
Pharmacology, toxicology, and microbiology only
Physical chemistry, organic chemistry, and biochemistry

Correct answer: Biomedical sciences, pharmaceutical sciences, and pharmacy practice

The Evaluating Examination blueprint covers biomedical sciences, pharmaceutical sciences, and pharmacy practice as its three major content areas.

Question 104: A pharmacist is counselling a patient who is visually impaired. The MOST appropriate adaptation is to:

Use larger printed materials only
Provide written materials in a larger font and end the consultation
Refer the patient to a specialized pharmacy
Offer verbal counselling, audio resources, or braille labels based on patient preference (Correct answer)

Correct answer: Offer verbal counselling, audio resources, or braille labels based on patient preference

Accessible care means offering multiple formats and asking the patient which modality they prefer.

Question 105: A pharmacist is counselling a patient newly prescribed warfarin. The patient states, 'I already know about this drug — my neighbor takes it.' Using the teach-back method, what is the MOST appropriate pharmacist response?

Provide a written leaflet and confirm the patient has read it before leaving.
Confirm the patient's prior knowledge by asking what their neighbor told them about warfarin.
Ask the patient to explain in their own words how they will know if warfarin is working too strongly. (Correct answer)
Proceed with abbreviated counselling since the patient has indirect exposure to the medication.

Correct answer: Ask the patient to explain in their own words how they will know if warfarin is working too strongly.

Teach-back requires the patient to demonstrate comprehension in their own words — not just acknowledge familiarity. Asking the patient to describe signs of supratherapeutic anticoagulation directly assesses understanding of a high-stakes safety concept. Relying on second-hand knowledge from a neighbor, distributing a leaflet without verification, or abbreviating counselling all fail to confirm individualized understanding and increase the risk of serious harm with a narrow-therapeutic-index drug.

Question 106: A 68-year-old patient with CKD stage 3b (eGFR 38 mL/min/1.73m²) presents with suspected digoxin toxicity. The serum digoxin level drawn 3 hours post-dose is 2.8 ng/mL. Which assessment consideration is MOST critical before concluding this represents true toxicity?

CKD reduces digoxin protein binding, requiring a lower toxic threshold of 1.5 ng/mL
The level should be re-drawn at trough to confirm toxicity only if the patient is symptomatic
Digoxin is primarily hepatically metabolized, so renal function is irrelevant to interpretation
Digoxin levels drawn less than 6–8 hours post-dose do not reflect true steady-state distribution and will falsely overestimate toxicity (Correct answer)

Correct answer: Digoxin levels drawn less than 6–8 hours post-dose do not reflect true steady-state distribution and will falsely overestimate toxicity

Digoxin has a prolonged distribution phase (6–8 hours post-dose). Levels drawn before full distribution is complete will reflect drug still equilibrating from the central compartment into tissues, giving spuriously elevated readings. In CKD, reduced renal clearance prolongs the half-life but does not change the post-distribution timing requirement. The correct clinical practice is to always interpret digoxin levels drawn at least 6–8 hours after the last dose; a 3-hour level of 2.8 ng/mL cannot be used to diagnose toxicity.

Question 107: What role does documentation play in clinical assessment methods?

It only matters for billing purposes
It is only needed for surgical procedures
It is optional but recommended
It is a critical legal and clinical requirement (Correct answer)

Correct answer: It is a critical legal and clinical requirement

Thorough documentation in clinical assessment methods is both a legal requirement and essential for continuity of patient care.

Question 108: A patient asks a pharmacist not to share their HIV medication history with their family physician. The pharmacist should:

Honour the request unless there is an overriding public safety concern (Correct answer)
Report the situation to the provincial college immediately
Refuse to dispense the medication until the patient consents to disclosure
Share the information anyway because the physician needs it for patient safety

Correct answer: Honour the request unless there is an overriding public safety concern

Patient confidentiality must be respected; disclosure without consent is only justified in specific legally defined circumstances.

Question 109: Which organization administers the PEBC Evaluating Examination and Qualifying Examinations in Canada?

Health Canada
The Pharmacy Examining Board of Canada (PEBC) (Correct answer)
The National Association of Pharmacy Regulatory Authorities (NAPRA)
The Canadian Pharmacists Association (CPhA)

Correct answer: The Pharmacy Examining Board of Canada (PEBC)

PEBC (Pharmacy Examining Board of Canada) is the national certification body that develops and administers these examinations.

Question 110: Which type of drug interaction occurs when two drugs compete for the same plasma protein binding sites?

Pharmacokinetic displacement interaction (Correct answer)
Enzyme induction
Receptor antagonism
Pharmacodynamic synergism

Correct answer: Pharmacokinetic displacement interaction

Displacement interactions occur when one drug displaces another from protein binding sites, transiently increasing the free (active) concentration of the displaced drug.

Question 111: What is the standard of care requirement for clinical assessment methods in clinical practice?

Whatever the practitioner feels is adequate
The minimum effort needed to avoid a lawsuit
The level of care a reasonably competent practitioner would provide (Correct answer)
The most aggressive treatment available

Correct answer: The level of care a reasonably competent practitioner would provide

The standard of care is defined as what a reasonably competent practitioner with similar training would provide under similar circumstances.

Question 112: The standard adult dose of a chemotherapy agent is 25 mg. A 9-year-old child weighs 28 kg and is 130 cm tall. Using the Mosteller BSA formula [BSA (m²) = √(height(cm) × weight(kg) / 3600)] and an adult reference BSA of 1.73 m², what is the appropriate pediatric dose (rounded to the nearest mg)?

15 mg (Correct answer)
18 mg
22 mg
10 mg

Correct answer: 15 mg

Step 1 — Child's BSA: √(130 × 28 / 3600) = √(3640 / 3600) = √1.0111 = 1.006 m². Step 2 — Proportional dose: (1.006 m² / 1.73 m²) × 25 mg = 0.5815 × 25 = 14.5 mg ≈ 15 mg. Choice C (18 mg) results from omitting the divide-by-3600 step, producing an inflated BSA. Choice D (22 mg) reflects use of Clark's rule (weight-based, 28/70 × 25 ≈ 10 mg) misapplied with adult weight of 30 kg. Choice A (10 mg) corresponds to direct application of Clark's rule with the standard 70 kg reference.

Question 113: Under PEBC standards, how long must a community pharmacy in most Canadian provinces retain prescription records?

5 years
10 years
1 year
2 years (Correct answer)

Correct answer: 2 years

Most provincial regulations require prescription records to be retained for a minimum of 2 years, though some provinces require longer retention periods.

Question 114: A patient with community-acquired pneumonia (CAP) and no comorbidities is treated in an outpatient setting. Per Canadian guidelines, what is the preferred first-line treatment?

Levofloxacin 750 mg daily for 5 days
Azithromycin 500 mg day 1, then 250 mg days 2–5
Amoxicillin-clavulanate 875/125 mg BID for 7 days
Doxycycline 100 mg BID for 5–7 days or amoxicillin 1 g TID (Correct answer)

Correct answer: Doxycycline 100 mg BID for 5–7 days or amoxicillin 1 g TID

Canadian guidelines recommend amoxicillin or doxycycline as first-line for outpatient CAP in otherwise healthy patients without recent antibiotic use.

Question 115: A pharmacy's electronic dispensing system experiences a data breach exposing patient medication records. What is the pharmacy's primary documentation obligation?

Delete all records to prevent further exposure
Document the breach details and notify affected individuals and the Privacy Commissioner as required under PIPEDA breach notification rules (Correct answer)
Internally note the breach but take no further action
Only notify patients if they specifically request information about the breach

Correct answer: Document the breach details and notify affected individuals and the Privacy Commissioner as required under PIPEDA breach notification rules

Under PIPEDA's breach of security safeguards provisions, pharmacies must document all breaches, notify affected individuals, and report significant breaches to the Privacy Commissioner.

Question 116: A TPN bag is compounded using 400 mL of 70% dextrose, 500 mL of 10% amino acids, and 100 mL of sterile water (total bag volume: 1000 mL). A 20% lipid emulsion piggyback of 250 mL is also ordered daily. What is the total daily caloric intake from this regimen?

1952 kcal
1652 kcal (Correct answer)
1427 kcal
1820 kcal

Correct answer: 1652 kcal

Dextrose: 400 mL × 0.70 = 280 g × 3.4 kcal/g = 952 kcal. Amino acids: 500 mL × 0.10 = 50 g × 4 kcal/g = 200 kcal. Lipids (20% emulsion): 250 mL × 2.0 kcal/mL = 500 kcal. Total = 952 + 200 + 500 = 1652 kcal. Option A uses 1.1 kcal/mL for the 20% lipid — that coefficient is for 10% emulsions. Option C applies 4 kcal/g to dextrose — the correct value for dextrose monohydrate in TPN is 3.4 kcal/g.

Question 117: A pharmacist reviews a patient's chart and notes they are taking warfarin (a narrow therapeutic index drug, >99% protein-bound) and a new antibiotic is added that is also highly protein-bound. The prescriber is concerned about a clinically significant protein-displacement interaction. What is the pharmacokinetic reality of this interaction?

Displacement raises free warfarin transiently, but the increased free drug is also subject to increased clearance, so steady-state free drug concentration is minimally affected (Correct answer)
Protein binding displacement increases the volume of distribution and prolongs the half-life of warfarin significantly
Displacement causes a sustained and clinically significant rise in free warfarin, requiring immediate dose reduction
The interaction is irrelevant because warfarin's narrow therapeutic index protects against displacement effects

Correct answer: Displacement raises free warfarin transiently, but the increased free drug is also subject to increased clearance, so steady-state free drug concentration is minimally affected

Protein-displacement interactions are frequently overstated. When a drug is displaced from plasma proteins, the transient rise in free drug concentration increases both its distribution into tissues and its clearance (hepatic and/or renal). At the new steady state, the total plasma concentration is lower but free concentration returns to near-baseline. For warfarin specifically, the real interaction risk with antibiotics is more often pharmacodynamic (altered vitamin K synthesis by gut flora) or pharmacokinetic via CYP2C9 inhibition—not simple displacement. Displacement does reduce total drug concentration and increases Vd slightly but does not prolong half-life significantly.

Question 118: A candidate discovers a third-party PEBC preparation course that advertises 'actual PEBC questions from recent administrations.' Under PEBC's exam security policies, what is the correct understanding of this claim, and what risk does using such a resource pose?

This is permissible because PEBC releases all retired questions to the public after each exam cycle, so third-party use of these questions is officially sanctioned
PEBC questions are confidential and protected; using materials that claim to contain actual exam questions may expose the candidate to academic integrity issues and reliance on potentially inaccurate reproduced content (Correct answer)
Third-party courses with actual PEBC questions are reviewed and endorsed by PEBC as supplementary preparation materials, provided they are from administrations more than five years old
The risk is minimal because PEBC regularly rotates all questions, making any 'actual' questions from previous years irrelevant to current exam performance

Correct answer: PEBC questions are confidential and protected; using materials that claim to contain actual exam questions may expose the candidate to academic integrity issues and reliance on potentially inaccurate reproduced content

PEBC maintains strict confidentiality of its exam items. PEBC does NOT release actual exam questions to the public after administrations. Third-party courses claiming to have 'actual PEBC questions' are either reproducing questions from memory (which is a violation of candidate agreements and potentially inaccurate) or making misleading claims. Using such materials may violate the candidate's signed confidentiality agreement with PEBC and risks studying from inaccurate content. Candidates should rely on PEBC's official sample questions and reputable resources.

Question 119: Tachyphylaxis refers to:

Rapid decrease in drug response following repeated administration (Correct answer)
Cross-reactivity between structurally similar drugs
Allergic reaction developing on repeated drug exposure
Increased sensitivity to a drug over time

Correct answer: Rapid decrease in drug response following repeated administration

Tachyphylaxis is a rapid, short-term decrease in response to a drug after repeated doses, often due to receptor desensitization or depletion of mediators.

Question 120: A pharmacist is counselling an elderly patient on a newly prescribed cholinesterase inhibitor for mild Alzheimer's disease. The patient's caregiver insists the pharmacist speak only to them and not involve the patient 'because they won't understand.' The patient appears oriented and is making eye contact. What should the pharmacist do?

Counsel both the patient and caregiver together, directing primary communication to the patient and supplementing with caregiver-directed information as appropriate (Correct answer)
Honour the caregiver's request to maintain the therapeutic relationship with the caregiver
Ask the caregiver to step outside and counsel only the patient to protect autonomy
Document the caregiver's preference and proceed with caregiver-only counselling to avoid conflict

Correct answer: Counsel both the patient and caregiver together, directing primary communication to the patient and supplementing with caregiver-directed information as appropriate

A patient with mild Alzheimer's retains decision-making capacity in the early stages and has the right to participate in their own care (autonomy). Excluding a present, apparently competent patient violates their dignity and provincial health consent legislation. The pharmacist should include the patient as the primary communicant—using clear, simple language—while also equipping the caregiver with the supplemental information they need for safe medication management. Excluding the caregiver entirely (option C) is also inappropriate given the caregiver's practical role in adherence support.

Question 121: A pharmacist who was licensed in France and has been practicing for 8 years applies to PEBC for credential recognition. Which statement most accurately describes how the PEBC will assess their foreign pharmacy degree?

Eight or more years of international practice automatically exempts the applicant from the Evaluating Examination under PEBC's experience equivalency policy.
PEBC evaluates foreign credentials using a document evaluation process and may require the applicant to sit the Evaluating Examination regardless of years of practice. (Correct answer)
The applicant must complete a Canadian pharmacy bridging program before any PEBC documentation can be submitted.
EU-credentialed pharmacists bypass PEBC evaluation under mutual recognition agreements between Canada and the European Union.

Correct answer: PEBC evaluates foreign credentials using a document evaluation process and may require the applicant to sit the Evaluating Examination regardless of years of practice.

PEBC assesses all internationally educated pharmacists through its credential evaluation process. Years of practice do not exempt an applicant from the Evaluating Examination (EE). There is no mutual recognition agreement between Canada and the EU, and a bridging program is not a prerequisite for submission — the evaluation and exam pathway are PEBC's standard route regardless of experience.

Question 122: During a pharmacy audit, an inspector notes that the perpetual narcotic register shows a running balance of 142 tablets for a controlled substance, but a physical count reveals only 138 tablets. The discrepancy is 4 tablets over a 30-day period. Under the Narcotic Control Regulations, what is the THRESHOLD and TIMELINE that triggers a mandatory reporting obligation to the Office of Controlled Substances?

Reporting is mandatory only when a specific employee has been identified as responsible, since unverified losses may be documentation errors rather than diversion
Only discrepancies exceeding 10 units trigger reporting; amounts of 4 tablets are documented in the internal discrepancy log only
Any loss or theft that is 'significant' must be reported to the Office of Controlled Substances as soon as possible, and 'significant' is determined by the pharmacist's professional judgment considering the size of the practice, but there is no fixed numerical threshold in the regulations (Correct answer)
A discrepancy of more than 1% of the total dispensed quantity within a 30-day period triggers mandatory immediate reporting regardless of circumstance

Correct answer: Any loss or theft that is 'significant' must be reported to the Office of Controlled Substances as soon as possible, and 'significant' is determined by the pharmacist's professional judgment considering the size of the practice, but there is no fixed numerical threshold in the regulations

The Narcotic Control Regulations (NCR) do not specify a fixed numerical threshold for reporting. Section 30 requires that any 'loss or theft' of a controlled substance be reported to Health Canada's Office of Controlled Substances 'as soon as possible.' The determination of whether a discrepancy constitutes a reportable loss versus a documentation error requires professional judgment — considering the pattern, magnitude relative to volume, whether explanations exist, and the practice context. This intentionally judgment-based standard means pharmacists cannot rely on a fixed number to avoid reporting; a pattern of small losses can be just as reportable as a single large one. The other options describe thresholds that do not exist in the regulations.

Question 123: A patient on carbamazepine is prescribed erythromycin for a respiratory infection. What patient safety concern must the pharmacist address?

Erythromycin inhibits CYP3A4, potentially causing carbamazepine toxicity (Correct answer)
Erythromycin reduces carbamazepine absorption
There is no clinically significant interaction
Carbamazepine accelerates erythromycin clearance, reducing antibiotic effect only

Correct answer: Erythromycin inhibits CYP3A4, potentially causing carbamazepine toxicity

Erythromycin is a CYP3A4 inhibitor; co-administration with carbamazepine (a CYP3A4 substrate) can cause carbamazepine accumulation and signs of toxicity.

Question 124: A patient asks the pharmacist not to tell their spouse, who is also a patient at the pharmacy, that they are taking HIV medication. The pharmacist should:

Suggest the patient inform their spouse themselves
Inform the spouse immediately to protect the household
Respect the patient's confidentiality, as personal health information cannot be shared without consent (Correct answer)
Tell the patient the spouse will find out on the pharmacy system

Correct answer: Respect the patient's confidentiality, as personal health information cannot be shared without consent

Patient confidentiality is a fundamental legal and ethical obligation; health information cannot be disclosed to third parties without explicit consent.

Question 125: A pharmacist provides emergency dispensing of a medication without a valid prescription. What documentation is required?

Document that the patient signed a liability waiver
Only record the patient's name and drug dispensed
Record the clinical rationale, quantity dispensed, attempts to contact the prescriber, and follow-up plan (Correct answer)
No documentation since it is an emergency

Correct answer: Record the clinical rationale, quantity dispensed, attempts to contact the prescriber, and follow-up plan

Emergency dispensing requires thorough documentation of clinical justification, quantity, efforts to reach the prescriber, and follow-up to obtain a valid prescription.

Question 126: A pharmacist is counselling a patient picking up a new opioid prescription when the patient reveals a specific, credible plan to physically harm an identified neighbour. The patient becomes agitated and leaves. Under Canadian law and pharmacy ethics, which of the following BEST describes the pharmacist's obligation?

The pharmacist's sole obligation is to notify the College of Pharmacists within 24 hours; all other action is beyond their professional scope.
Pharmacist-patient confidentiality is near-absolute; the pharmacist may only document the disclosure internally and monitor future visits.
The pharmacist may disclose to the identified third party and law enforcement when there is a serious, credible, and imminent threat to an identifiable person. (Correct answer)
The pharmacist must first attempt to obtain the patient's written consent before any disclosure can be made, even to police.

Correct answer: The pharmacist may disclose to the identified third party and law enforcement when there is a serious, credible, and imminent threat to an identifiable person.

Canadian common law and privacy legislation (including PIPEDA and provincial health information acts) recognize a 'duty to warn' exception to confidentiality when a threat is serious, credible, and directed at an identifiable person. In such cases, disclosure to the potential victim and law enforcement is not only permitted but may be ethically required. Confidentiality is not absolute, and waiting for patient consent or limiting action to College notification fails to adequately protect the third party.

Question 127: During a medication review, a First Nations patient declines a pharmacist's offer to demonstrate a new inhaler technique, stating, 'My grandmother taught me the traditional way to breathe for healing and that is what I will follow.' The patient's current inhaler technique appears ineffective based on observed symptom control. Which approach BEST reflects culturally safe pharmacy practice?

Defer entirely to the patient's cultural preferences and document that education was offered but declined
Refer the patient to their physician to address the technique issue, as cultural sensitivity is beyond the pharmacist's scope
Explain that evidence-based inhaler technique is essential for efficacy and respectfully insist on a demonstration
Acknowledge the significance of the traditional practice, explore how both approaches might complement each other, and share clinical concerns about symptom control without dismissing the patient's beliefs (Correct answer)

Correct answer: Acknowledge the significance of the traditional practice, explore how both approaches might complement each other, and share clinical concerns about symptom control without dismissing the patient's beliefs

Culturally safe practice requires more than tolerance — it demands active engagement that acknowledges the validity of the patient's worldview while still fulfilling the pharmacist's professional obligation to optimize therapeutic outcomes. Simply deferring (option B) abdicates professional responsibility. Insisting on the biomedical approach (option C) is culturally unsafe. Referring to the physician (option D) avoids the issue. The correct approach opens dialogue, validates the patient's cultural identity, and collaboratively explores how clinical concerns can be addressed without marginalizing their beliefs.

Question 128: A 58-year-old patient on warfarin presents with an INR of 1.8 (target 2.0–3.0). The prescriber suspects non-adherence but the patient insists they have been compliant. Which laboratory finding would most strongly suggest a pharmacokinetic drug interaction rather than non-adherence as the cause of the subtherapeutic INR?

A platelet count below 150 × 10⁹/L on the same CBC
A recent doubling of serum cholestyramine co-administration documented in the medication list (Correct answer)
A concurrent rise in serum albumin with no change in bilirubin
An elevated vitamin K epoxide reductase (VKORC1) activity on genetic testing

Correct answer: A recent doubling of serum cholestyramine co-administration documented in the medication list

Cholestyramine (a bile acid sequestrant) binds warfarin in the GI tract and significantly reduces its absorption, lowering the INR despite patient adherence. This represents a documented pharmacokinetic interaction at the absorption level. Serum albumin changes would affect protein binding but rarely reduce INR to this extent acutely. VKORC1 variants affect pharmacodynamics (warfarin sensitivity at initiation) rather than explaining a sudden drop in a previously stable patient. Thrombocytopenia would not explain a low INR.

Question 129: A pharmacist is preparing a batch of suppositories using cocoa butter as the base. Which mold displacement factor consideration is critical for accurate dosing?

Aqueous APIs cannot be incorporated into cocoa butter
The API always weighs less than cocoa butter by volume
The density factor of the API must be used to adjust base quantity (Correct answer)
Cocoa butter expands on cooling, requiring overfill

Correct answer: The density factor of the API must be used to adjust base quantity

The density (displacement) factor of the active ingredient relative to cocoa butter must be used to calculate how much base to subtract so each suppository contains the correct drug dose.

Question 130: A patient on lithium therapy has a serum lithium level of 1.8 mmol/L. The therapeutic range is 0.6–1.2 mmol/L. Which symptom is most consistent with lithium toxicity?

Coarse tremor, ataxia, and confusion (Correct answer)
Polyuria and polydipsia
Fine hand tremor
Weight gain and hypothyroidism

Correct answer: Coarse tremor, ataxia, and confusion

Serum lithium > 1.5 mmol/L indicates serious toxicity, manifesting as coarse tremor, ataxia, confusion, and in severe cases, seizures or coma.

Question 131: A patient taking phenytoin for seizures is prescribed fluconazole for a fungal infection. What is the expected pharmacokinetic outcome?

Phenytoin reduces fluconazole efficacy via P-glycoprotein induction
No significant interaction exists between these two drugs
Fluconazole inhibits CYP2C9, increasing phenytoin levels and toxicity risk (Correct answer)
Fluconazole induces CYP2C9, reducing phenytoin levels

Correct answer: Fluconazole inhibits CYP2C9, increasing phenytoin levels and toxicity risk

Fluconazole is a potent CYP2C9 inhibitor; since phenytoin is primarily metabolized by CYP2C9, co-administration can lead to significantly elevated phenytoin levels and toxicity.

Question 132: Which monitoring parameter is MOST important to assess within the first 1–2 weeks of initiating an ACE inhibitor in a patient with hypertension and mild CKD?

Serum potassium and creatinine (Correct answer)
Liver function tests
Complete blood count
Serum sodium and chloride

Correct answer: Serum potassium and creatinine

ACE inhibitors can cause hyperkalemia and an acute rise in serum creatinine, particularly in patients with CKD, making early electrolyte and renal function monitoring essential.

Question 133: A prescription reads: 'Take 1 tablespoon three times daily for 10 days.' How many mL of medication must be dispensed to fill this prescription exactly?

450 mL (Correct answer)
300 mL
150 mL
500 mL

Correct answer: 450 mL

1 tablespoon = 15 mL; 15 mL × 3 doses/day × 10 days = 450 mL.

Question 134: In the context of the PEBC Pharmacy Technician Qualifying Examination, which statement most precisely characterizes the relationship between the Written and Practical components in determining a candidate's final result?

The Written component serves as a prerequisite gate: only candidates who pass Written may proceed to Practical, but the final result is based solely on Practical performance.
The two components are combined into a single composite score, and a candidate may compensate for a weak Practical performance with a strong Written result.
Both components must be passed independently; passing one component does not exempt the candidate from the other, and each has its own separate pass standard. (Correct answer)
Candidates who fail only the Practical component on their first attempt are automatically granted one supervised remediation session before a reassessment.

Correct answer: Both components must be passed independently; passing one component does not exempt the candidate from the other, and each has its own separate pass standard.

The PEBC Pharmacy Technician Qualifying Examination requires candidates to meet the pass standard on both the Written component and the Practical component independently. Each has its own minimum passing threshold. Strong performance on the Written examination cannot compensate for a failure on the Practical, nor vice versa — compensation across components is not permitted. This dual-independent-pass structure ensures that both theoretical knowledge and procedural/dispensing competencies are each verified to a minimum standard.

Question 135: A 15-year-old presents a valid prescription for combined oral contraceptives and explicitly requests that no information be shared with her parents, stating she fears a violent reaction at home. She demonstrates clear understanding of the medication, its risks, and alternatives. Under Canadian common law and provincial privacy legislation, which principle PRIMARILY governs whether this dispensing can occur without parental consent or disclosure?

The principle of therapeutic privilege — the pharmacist may override parental rights if disclosure would cause psychological harm to the patient
The mature minor doctrine — capacity is assessed individually based on the minor's demonstrated ability to understand and appreciate the nature and consequences of the treatment decision (Correct answer)
Parens patriae jurisdiction — a pharmacist must refer to the court when parental consent is withheld for minors under 18
The age of majority threshold — most provinces set independent consent at 16, making parental consent legally mandatory here

Correct answer: The mature minor doctrine — capacity is assessed individually based on the minor's demonstrated ability to understand and appreciate the nature and consequences of the treatment decision

Canadian common law recognizes the 'mature minor doctrine,' originating from cases like A.C. v. Manitoba (2009, SCC). Consent capacity is not determined by age alone but by whether the individual understands the nature of the treatment, its risks, benefits, and alternatives, and can appreciate the consequences. A 15-year-old who demonstrates this capacity can consent independently. Provincial privacy legislation (e.g., PHIPA in Ontario) similarly protects health information of capable minors from parental access. The age of majority governs civil contracts, not health consent. Parens patriae applies when a minor lacks capacity or is endangered, not as a default barrier.

Question 136: A patient's stool culture is positive for Clostridioides difficile toxin. Which test characteristic makes the PCR assay preferred over enzyme immunoassay (EIA) for toxin detection?

Lower cost per test
Ability to detect all Gram-positive bacteria
Higher sensitivity for detecting toxin genes (Correct answer)
Shorter turnaround time only

Correct answer: Higher sensitivity for detecting toxin genes

PCR-based testing detects the toxin gene with higher sensitivity than EIA toxin detection, reducing the rate of false-negative results in C. difficile infection diagnosis.

Question 137: The doctrine of 'respondeat superior' in pharmacy law means:

A pharmacist must defer to the supervising physician at all times
The regulatory college is responsible for all licensee misconduct
An employer may be liable for the negligent acts of an employee pharmacist (Correct answer)
Patients are responsible for following medication instructions

Correct answer: An employer may be liable for the negligent acts of an employee pharmacist

Respondeat superior holds employers vicariously liable for negligent acts of employees performed within the scope of employment.

Question 138: A candidate fails PEBC QE Part I for the third time. According to PEBC policy, what is the MOST accurate description of their situation regarding future attempts?

They are permanently barred from re-attempting QE Part I and must retake the Evaluating Examination
They must wait a mandatory 2-year period and may be required to demonstrate additional competency measures before re-registering (Correct answer)
They may re-register immediately for the next available administration with no restrictions
They must obtain written endorsement from their provincial regulatory authority before a fourth attempt is permitted

Correct answer: They must wait a mandatory 2-year period and may be required to demonstrate additional competency measures before re-registering

PEBC policy imposes a mandatory waiting period and potential remediation requirements after a candidate exhausts three attempts at QE Part I. This is distinct from a permanent bar or a simple re-registration; the candidate must satisfy PEBC's re-entry conditions, which can include additional training or documentation, before being eligible for a fourth attempt.

Question 139: During a prescription pickup, a patient reveals they have been skipping doses because they cannot afford the medication. The pharmacist's FIRST action should be:

Dispense the medication and say nothing to avoid embarrassment
Document non-adherence and end the consultation
Explore drug coverage options, generic alternatives, or patient assistance programs (Correct answer)
Contact the prescriber immediately to change the therapy

Correct answer: Explore drug coverage options, generic alternatives, or patient assistance programs

Identifying affordability barriers and offering solutions is a key pharmacist role in supporting adherence.

Question 140: A 30-year-old woman with epilepsy on valproic acid 1000 mg/day is planning a pregnancy. What is the pharmacist's MOST important recommendation?

Switch to carbamazepine and take folic acid 1 mg/day
Switch to levetiracetam before conception and start high-dose folic acid 5 mg/day (Correct answer)
Discontinue all antiepileptic therapy before attempting conception
Continue valproic acid and take standard folic acid 0.4 mg/day

Correct answer: Switch to levetiracetam before conception and start high-dose folic acid 5 mg/day

Valproic acid carries the highest teratogenic risk among antiepileptics; pre-conception transition to a safer agent plus high-dose folic acid (5 mg/day) is strongly recommended.

Question 141: What is the first step in the PEBC certification process?

Submitting documents for evaluation (Correct answer)
Completing an internship
Passing the qualifying exam
Attending a preparatory workshop

Correct answer: Submitting documents for evaluation

The very first step in the PEBC certification process for pharmacists is submitting documents for evaluation. This initial stage involves providing academic transcripts, professional credentials, and other required paperwork to the PEBC for verification. This ensures that candidates meet the basic educational and professional eligibility criteria before proceeding to the evaluating or qualifying exams.

Question 142: A pharmacy student on rotation witnesses a preceptor pharmacist dispensing without completing a required counselling step. The student's best course of action is to:

Immediately file a complaint with the provincial regulatory college
Raise the concern with the preceptor privately, then escalate if needed (Correct answer)
Complete the counselling themselves without informing anyone
Ignore it to avoid jeopardizing the placement

Correct answer: Raise the concern with the preceptor privately, then escalate if needed

Professional responsibility requires addressing observed safety issues directly and respectfully before escalating through formal channels.

Question 143: Which laboratory result is a contraindication to initiating metformin therapy?

eGFR 55 mL/min/1.73m²
eGFR 28 mL/min/1.73m² (Correct answer)
Fasting glucose 9.2 mmol/L
HbA1c 8.5%

Correct answer: eGFR 28 mL/min/1.73m²

Metformin is contraindicated when eGFR < 30 mL/min/1.73m² due to the risk of lactic acidosis from drug accumulation; caution is advised at eGFR 30–45.

Question 144: An inhibitor of CYP3A4 is co-administered with a drug that is a substrate of CYP3A4 AND undergoes extensive first-pass metabolism. Which outcome best describes the net pharmacokinetic effect on the substrate?

Decreased AUC due to increased P-glycoprotein efflux at the gut wall
Decreased AUC due to competitive displacement from plasma proteins
Increased AUC due to reduced presystemic and systemic metabolism (Correct answer)
Unchanged AUC because renal clearance compensates for reduced hepatic metabolism

Correct answer: Increased AUC due to reduced presystemic and systemic metabolism

CYP3A4 inhibition impairs both intestinal (presystemic/first-pass) and hepatic metabolism of the substrate. When first-pass metabolism is high, even a small reduction in CYP3A4 activity can dramatically increase bioavailability, leading to a disproportionately large increase in AUC. P-glycoprotein efflux is a separate mechanism and not compensatory for CYP inhibition. Protein displacement and renal clearance are not relevant pathways here.

Question 145: A drug follows zero-order kinetics at therapeutic plasma concentrations. Which of the following clinical consequences is MOST directly attributable to this kinetic behavior?

The drug is always eliminated more rapidly than first-order drugs at equivalent concentrations
Small dose increases can cause disproportionately large increases in steady-state plasma concentrations (Correct answer)
A constant fraction of drug is eliminated per unit time, allowing predictable dosing
Doubling the dose doubles the plasma half-life but not the concentration

Correct answer: Small dose increases can cause disproportionately large increases in steady-state plasma concentrations

In zero-order kinetics, a constant amount (not fraction) of drug is eliminated per unit time because the elimination pathway is saturated. As a result, steady-state plasma concentration increases non-linearly with dose — small dose increments can lead to disproportionately large accumulation, making toxicity unpredictable. Phenytoin and ethanol are classic examples. It is NOT true that a constant fraction is eliminated (that describes first-order kinetics). Zero-order drugs do not have a fixed half-life; the apparent half-life increases as dose increases.

Question 146: Passive diffusion across a cell membrane is MOST dependent on which drug property?

Molecular weight only
Protein binding percentage
Water solubility
Lipid solubility and degree of ionization (Correct answer)

Correct answer: Lipid solubility and degree of ionization

Passive diffusion is governed primarily by a drug's lipid solubility and its un-ionized fraction, as only non-ionized, lipophilic forms cross membranes readily.

Question 147: Which of the following best describes a pharmacy's duty under 'duty to warn' in the context of drug interactions?

Pharmacists must only warn patients about interactions listed in the provincial formulary
Pharmacists must proactively counsel patients about clinically significant drug interactions identified during dispensing (Correct answer)
Warning patients about drug interactions is the exclusive responsibility of the prescribing physician
Duty to warn applies only when the patient specifically requests drug interaction information

Correct answer: Pharmacists must proactively counsel patients about clinically significant drug interactions identified during dispensing

Pharmacists have a professional and legal duty to counsel patients about clinically significant interactions discovered during the medication review process, regardless of whether the patient asks.

Question 148: Which ethical principle is most directly applicable to pharmacology basics?

Beneficence — acting in the patient's best interest (Correct answer)
Prioritize speed over thoroughness
Follow the most convenient protocol
Maximize facility revenue

Correct answer: Beneficence — acting in the patient's best interest

Beneficence, the principle of acting in the patient's best interest, is fundamental to ethical practice in pharmacology basics.

Question 149: A community pharmacist is performing a structured adherence assessment using pill counts supplemented by pharmacy refill records (MPR calculation). The patient's MPR for their antihypertensive is 0.93 over 12 months, yet their BP remains uncontrolled at 158/96 mmHg at every visit. Which phenomenon MOST likely accounts for this discrepancy and should be documented in the pharmacist's assessment?

The 'white-coat' or 'parking-lot' adherence effect: the patient fills prescriptions regularly but takes medication selectively, with clustering of doses around refill or clinic dates (Correct answer)
Pill count and MPR are direct adherence measures and together eliminate the possibility of non-adherence as the cause of uncontrolled BP
MPR >0.90 is the gold standard confirming true adherence; therefore, the cause must be therapeutic resistance, and a dose increase is the only logical next step
The pharmacist should suspect a laboratory error in BP measurement before concluding that adherence or pharmacological failure is responsible

Correct answer: The 'white-coat' or 'parking-lot' adherence effect: the patient fills prescriptions regularly but takes medication selectively, with clustering of doses around refill or clinic dates

MPR and pill counts are indirect adherence measures — they capture possession and dispensing, not actual ingestion. 'White-coat adherence' (also called 'toothbrush adherence' or adherence clustering) is well-documented: patients who are otherwise non-adherent increase pill-taking days before clinic visits or refill dates, producing artificially high MPR values while maintaining subtherapeutic drug exposure between those windows. This explains how MPR ≥0.90 can coexist with consistently uncontrolled BP. Documenting this pattern is critical before escalating therapy — dose increases in a non-adherent patient are ineffective and potentially harmful. Direct measures (e.g., drug urine/blood levels, electronic pill caps) are needed to confirm.

Question 150: A patient reports taking their antihypertensive medications only on days they 'feel their blood pressure is high.' This pattern indicates:

Intentional non-adherence based on health beliefs (Correct answer)
Appropriate dose titration by the patient
Medication intolerance requiring a drug change
Adequate symptom-based self-management

Correct answer: Intentional non-adherence based on health beliefs

Taking medications only when symptomatic reflects intentional non-adherence driven by health beliefs, as hypertension is typically asymptomatic.

Question 151: A patient with HIV is initiated on an antiretroviral regimen containing tenofovir disoproxil fumarate (TDF). Which organ function requires close monitoring?

Renal function (serum creatinine, eGFR) and bone density (Correct answer)
Pulmonary function (FEV1)
Thyroid function (TSH)
Hepatic function (ALT/AST)

Correct answer: Renal function (serum creatinine, eGFR) and bone density

TDF is associated with nephrotoxicity and decreased bone mineral density; renal function and bone density monitoring are key components of TDF-based regimen follow-up.

Question 152: During a medication reconciliation process on hospital admission, a pharmacist identifies that a patient's home medication list includes warfarin 5 mg daily, but the admitting physician ordered warfarin 2.5 mg daily citing 'renal dosing.' The patient's eGFR is 62 mL/min/1.73m². Which pharmacist action BEST reflects evidence-based practice and professional responsibility?

Order a STAT INR and hold all warfarin pending the result, then consult the physician with the INR value before making any recommendation
Accept the physician's order because clinical judgment on dosing adjustments is within the physician's scope and warfarin does carry renal precautions in some references
Flag the discrepancy in the chart and recommend a hematology consult, as warfarin titration in CKD requires specialist oversight per PEBC standards
Intervene immediately: warfarin does not require renal dose adjustment at eGFR 62, so the home dose should be verified with the anticoagulation clinic and reconciled back to 5 mg pending INR review (Correct answer)

Correct answer: Intervene immediately: warfarin does not require renal dose adjustment at eGFR 62, so the home dose should be verified with the anticoagulation clinic and reconciled back to 5 mg pending INR review

Warfarin is NOT renally dosed; its metabolism is hepatic (CYP2C9) and the rationale of 'renal dosing' at eGFR 62 is pharmacologically incorrect. The correct action is to identify the prescribing error, verify the patient's established dose with their anticoagulation clinic or previous INR records, and communicate the discrepancy to the physician with a recommendation to restore the home dose—pending INR assessment. Simply holding the drug or accepting an erroneous rationale without intervention fails the pharmacist's duty to optimize medication therapy and prevent harm.

Question 153: Under Canadian privacy law, which of the following is a valid reason to disclose patient information without consent?

A family member requests the information for caregiving
Another pharmacist in a different pharmacy chain asks for it
The patient has not visited the pharmacy in over one year
A law enforcement officer presents a valid court order (Correct answer)

Correct answer: A law enforcement officer presents a valid court order

A valid court order or subpoena is a legally recognized basis for disclosing patient information without prior consent.

Question 154: Which statement about drug half-life in first-order kinetics is TRUE?

Half-life is independent of the initial dose or concentration (Correct answer)
Half-life equals the time for 50% receptor occupancy
Half-life increases as plasma concentration increases
Half-life is doubled in zero-order kinetics

Correct answer: Half-life is independent of the initial dose or concentration

In first-order kinetics, half-life is constant (t½ = 0.693/ke) and does not depend on the drug concentration or dose.

Question 155: During a medication review, a patient with moderate hearing loss repeatedly nods and says 'yes' but gives incorrect answers when asked to repeat back instructions. The pharmacist suspects the patient did not understand. Which communication strategy is MOST effective at this point?

Refer the patient to their physician for counselling, as the pharmacy environment is too noisy
Hand the patient a printed monograph and ask them to read it at home
Speak louder and more slowly, repeating the same verbal instructions
Use the teach-back method with written key points, facing the patient to allow lip-reading, and confirm comprehension step-by-step (Correct answer)

Correct answer: Use the teach-back method with written key points, facing the patient to allow lip-reading, and confirm comprehension step-by-step

Simply increasing volume can distort speech sounds for hearing aid users and does not confirm understanding. Teach-back (asking the patient to explain back in their own words) is the gold-standard technique to verify comprehension, not just compliance cues like nodding. Facing the patient allows lip-reading and visual cues, and coupling verbal explanation with written key points accommodates multiple sensory channels. Referral to a physician is inappropriate for medication counselling within pharmacy scope.

Question 156: Which of the following is the correct approach to documenting a refusal of counselling by a patient?

Record that counselling was offered and declined by the patient (Correct answer)
Contact the prescriber to report the refusal
No documentation is required if the patient refuses
Force the patient to accept counselling before dispensing

Correct answer: Record that counselling was offered and declined by the patient

Documenting that counselling was offered but declined demonstrates professional due diligence and fulfills regulatory obligations.

Question 157: A 58-year-old male with type 2 diabetes presents with an HbA1c of 7.4% but his fasting plasma glucose readings at home consistently show values between 9.0–11.0 mmol/L. Which condition BEST explains this discrepancy?

Iron deficiency anemia causing falsely elevated HbA1c
Laboratory calibration error in the immunoassay method
Post-prandial hyperglycemia masked by nocturnal hypoglycemia
Hemolytic anemia causing falsely low HbA1c (Correct answer)

Correct answer: Hemolytic anemia causing falsely low HbA1c

Hemolytic anemia reduces RBC lifespan, meaning fewer red blood cells are exposed to glucose for the full 120-day period. This leads to a falsely LOW HbA1c relative to actual glycemic control. The patient's home glucose readings of 9–11 mmol/L are more reflective of true hyperglycemia. Clinicians should use fructosamine or continuous glucose monitoring in patients with hemolytic conditions.

Question 158: Which pharmacokinetic parameter describes the fraction of an administered drug that reaches systemic circulation unchanged?

Volume of distribution
Bioavailability (Correct answer)
Clearance
Half-life

Correct answer: Bioavailability

Bioavailability (F) represents the fraction of a drug dose that reaches systemic circulation in an active form after administration.

Question 159: During a medication therapy management visit, you assess a patient's adherence using the Morisky Medication Adherence Scale (MMAS-8). The patient scores 6 out of 8. When interpreting this result to guide clinical action, which limitation of this tool is MOST critical to acknowledge?

A score of 6 falls in the high-adherence category and requires no further intervention
Self-report bias leads to systematic overestimation of adherence; a score of 6 may reflect lower true adherence than indicated (Correct answer)
The MMAS-8 is not validated in Canadian pharmacy populations and should not be used
The MMAS-8 only captures intentional non-adherence and misses unintentional errors

Correct answer: Self-report bias leads to systematic overestimation of adherence; a score of 6 may reflect lower true adherence than indicated

The MMAS-8 is a self-report tool subject to social desirability bias — patients systematically overreport adherence. A score of 6/8 places the patient in the 'medium adherence' category (scores ≥ 8 = high, 6–7 = medium, < 6 = low), but the actual adherence is likely lower than reported. This is the most clinically critical limitation when deciding intervention intensity. The MMAS-8 does capture both intentional and unintentional non-adherence types across its items, and it is used in Canadian practice research.

Question 160: What are the main components of the PEBC Qualifying Exam?

Practical lab work only
MCQ and OSCE (Correct answer)
Group discussion sessions
Only written essays

Correct answer: MCQ and OSCE

The PEBC Qualifying Exam, a crucial step for licensure, is comprised of two main components: a Multiple-Choice Question (MCQ) examination and an Objective Structured Clinical Examination (OSCE). The MCQ assesses theoretical knowledge and understanding of pharmaceutical sciences, while the OSCE evaluates practical clinical skills and communication abilities. Both parts are essential to comprehensively assess a candidate's readiness for pharmacy practice.

Question 161: A pharmacist is using motivational interviewing (MI) to address medication non-adherence in a patient with uncontrolled hypertension. The patient states: 'I know I should take my pills, but I just don't think they're making any difference.' Which pharmacist response BEST reflects advanced MI technique?

'It sounds like you're frustrated that you're putting in the effort but not seeing the results you hoped for. What would 'making a difference' look like to you?' (Correct answer)
'Your blood pressure readings show they are working—you really need to take them consistently.'
'Would you be willing to try a 30-day adherence challenge and see if your numbers improve?'
'A lot of patients feel that way at first. Let me explain how antihypertensives lower your cardiovascular risk over time.'

Correct answer: 'It sounds like you're frustrated that you're putting in the effort but not seeing the results you hoped for. What would 'making a difference' look like to you?'

Advanced MI uses complex reflections and open-ended questions to explore the patient's own values and meaning—not to convince or educate. Option B reflects the patient's emotional ambivalence ('frustrated'), validates their perspective without judgment, and uses an open-ended question ('What would making a difference look like?') to elicit the patient's own definition of success—a core MI strategy that surfaces intrinsic motivation. Option A is confrontational (the 'righting reflex'). Option C provides unsolicited education (information-pushing), which can trigger reactance. Option D is a closed-ended challenge that bypasses the patient's underlying ambivalence.

Question 162: Which of the following is a Type A (augmented) adverse drug reaction?

Bradycardia and hypotension from an excessive dose of metoprolol (Correct answer)
Anaphylaxis to penicillin in a sensitized patient
Drug-induced agranulocytosis from carbamazepine
Stevens-Johnson syndrome from allopurinol

Correct answer: Bradycardia and hypotension from an excessive dose of metoprolol

Type A adverse drug reactions are dose-dependent, predictable extensions of the drug's known pharmacological effect. Bradycardia from beta-blocker overdose is a predictable, dose-related ADR. Types B (bizarre) reactions like anaphylaxis and SJS are idiosyncratic and not related to normal pharmacology.

Question 163: A patient's medication profile shows a documented allergy to penicillin. A prescriber orders amoxicillin. What is the required documentation step after intervening?

Only document if the prescriber insists on the order
Dispense the medication since the prescriber ordered it and document nothing
Document the allergy conflict identified, communication with the prescriber, and the outcome (Correct answer)
Remove the allergy notation as it may be outdated

Correct answer: Document the allergy conflict identified, communication with the prescriber, and the outcome

All clinical interventions, including allergy conflicts flagged to prescribers, must be documented with the outcome to demonstrate patient safety actions taken.

Question 164: A colleague asks a pharmacist to sign off on a controlled substance count they did not personally witness. The pharmacist should:

Refuse to sign and conduct or witness the count themselves (Correct answer)
Report the colleague to the provincial college immediately
Sign but note the discrepancy in private records
Sign as a professional courtesy to the colleague

Correct answer: Refuse to sign and conduct or witness the count themselves

Signing documentation you did not personally verify is fraudulent and violates professional integrity standards.

Question 165: Which of the following is the primary purpose of a formulary in a hospital or managed care pharmacy setting?

To rank pharmacists by their prescription volume
To list all drugs available for purchase by patients without a prescription
To provide a curated list of approved medications that promote safe, effective, and cost-efficient prescribing (Correct answer)
To document adverse drug reactions for regulatory reporting

Correct answer: To provide a curated list of approved medications that promote safe, effective, and cost-efficient prescribing

A formulary is a curated, evidence-based drug list used to guide prescribing decisions, promote therapeutic appropriateness, and manage costs.

Question 166: Under the Controlled Drugs and Substances Act, a pharmacy discovers a discrepancy in its narcotic inventory. What is the correct documentation response?

Dispose of excess inventory immediately without documentation
Transfer the discrepancy to another pharmacy's records
Document the discrepancy, investigate, and report to Health Canada if loss or theft is suspected (Correct answer)
Adjust the register to match current stock without noting the discrepancy

Correct answer: Document the discrepancy, investigate, and report to Health Canada if loss or theft is suspected

Narcotic discrepancies must be documented, investigated, and reported to Health Canada if theft or significant loss is suspected under CDSA requirements.

Question 167: Which finding on a urinalysis would most suggest a urinary tract infection?

Trace protein and trace glucose
Positive nitrite and positive leukocyte esterase (Correct answer)
Specific gravity 1.010, pH 6.0
Specific gravity 1.030 with ketones

Correct answer: Positive nitrite and positive leukocyte esterase

Positive nitrite (bacterial nitrate reduction) combined with positive leukocyte esterase (pyuria) strongly suggests a bacterial urinary tract infection.

Question 168: A 70-year-old patient's serum creatinine is within normal limits but their eGFR is 52 mL/min/1.73m². What does this discrepancy reflect?

Laboratory error in creatinine measurement
Fluid overload diluting serum creatinine
Age-related decrease in muscle mass leading to lower creatinine production (Correct answer)
Increased dietary protein intake elevating creatinine

Correct answer: Age-related decrease in muscle mass leading to lower creatinine production

Elderly patients have reduced muscle mass and thus lower creatinine production, causing serum creatinine to appear normal despite significantly reduced GFR.

Question 169: A candidate who has passed the PEBC Qualifying Examinations but has not yet obtained provincial licensure works as a pharmacy assistant. Which of the following is true?

They must work under the supervision of a licensed pharmacist and cannot perform restricted acts (Correct answer)
They may counsel patients independently under PEBC authorization
Their PEBC certificate allows them to dispense medications without a provincial license
They may apply for a temporary PEBC practice permit for up to 6 months

Correct answer: They must work under the supervision of a licensed pharmacist and cannot perform restricted acts

Without provincial licensure, a candidate cannot independently perform restricted pharmacist activities and must work under the supervision of a licensed pharmacist.

Question 170: A 68-year-old patient with chronic kidney disease (CrCl = 18 mL/min) requires an antibiotic that is 85% renally excreted unchanged. Compared to a patient with normal renal function (CrCl = 110 mL/min), which dosing adjustment strategy is pharmacokinetically MOST appropriate?

Maintain the same loading dose but increase the dosing interval or reduce the maintenance dose (Correct answer)
Reduce the loading dose proportionally to the decrease in CrCl
Halve both the loading dose and maintenance dose to avoid accumulation
No adjustment needed because hepatic metabolism compensates for reduced renal clearance

Correct answer: Maintain the same loading dose but increase the dosing interval or reduce the maintenance dose

The loading dose is determined by Vd and target concentration — since renal impairment does not significantly alter Vd, the loading dose remains unchanged (to rapidly achieve therapeutic levels). However, maintenance dosing must be adjusted because the elimination rate constant (ke) is reduced proportionally to CrCl. This is achieved by either extending the dosing interval (τ) or reducing the maintenance dose — or a combination. Reducing the loading dose delays achieving therapeutic concentrations unnecessarily and is a common error.

Question 171: A patient newly diagnosed with type 2 diabetes has an A1C of 9.5% and is otherwise healthy. According to Canadian Diabetes Association guidelines, what is the preferred initial pharmacotherapy?

Lifestyle modification alone for 3 months before initiating any drug
Metformin monotherapy titrated to maximum tolerated dose
Insulin glargine once daily as A1C is above 9%
Metformin plus a second agent due to high A1C unlikely to be controlled with monotherapy (Correct answer)

Correct answer: Metformin plus a second agent due to high A1C unlikely to be controlled with monotherapy

Canadian guidelines recommend combination therapy at diagnosis when A1C is ≥1.5% above target, as monotherapy is unlikely to achieve glycemic goals in this scenario.

Question 172: What role does documentation play in pharmacology basics?

It is only needed for surgical procedures
It is a critical legal and clinical requirement (Correct answer)
It is optional but recommended
It only matters for billing purposes

Correct answer: It is a critical legal and clinical requirement

Thorough documentation in pharmacology basics is both a legal requirement and essential for continuity of patient care.

Question 173: What happens after successfully completing the Qualifying Exam?

Candidates receive temporary licensure
The certification process is complete
Candidates can apply for provincial licensure (Correct answer)
Candidates must retake the OSCE

Correct answer: Candidates can apply for provincial licensure

After successfully completing the PEBC Qualifying Exam, candidates receive a Certificate of Qualification from the PEBC. This certificate is a national standard that then allows them to apply for licensure with a provincial or territorial regulatory body. Each province or territory has its own additional requirements, such as internships or jurisprudence exams, before full licensure is granted.

Question 174: A pharmacy technician initials a narcotic count discrepancy entry in the narcotics register before the pharmacist has verified and countersigned it. Under the Controlled Drugs and Substances Act documentation requirements, what is the correct course of action?

The technician's entry is acceptable as long as the pharmacist countersigns within the same business day
The entry is invalid and a new corrected entry must be made, with the original entry crossed out and initialled by both the pharmacist and technician
The pharmacist must investigate the discrepancy, document the findings, and countersign the entry; the technician's premature initialling must also be noted (Correct answer)
Only the pharmacist may make entries in the narcotics register; the technician's entry must be voided entirely

Correct answer: The pharmacist must investigate the discrepancy, document the findings, and countersign the entry; the technician's premature initialling must also be noted

Under CDSA regulations, narcotics records require pharmacist oversight and countersignature. When a discrepancy exists, the pharmacist bears accountability for investigation and documentation of the resolution. The technician initialling prematurely does not invalidate the entry outright, but the pharmacist must document the investigation findings and countersign. Creating an entirely new entry or voiding the original is not the standard approach — corrections to controlled substance records should be made transparently with annotations, not deletions.

Question 175: A patient's eGFR is reported as 28 mL/min/1.73m². According to KDIGO staging, this patient has:

CKD Stage 4 (Correct answer)
CKD Stage 2
CKD Stage 3b
CKD Stage 5

Correct answer: CKD Stage 4

KDIGO Stage 4 CKD corresponds to an eGFR of 15–29 mL/min/1.73m², indicating severely decreased kidney function.

Question 176: When selecting an antibiotic for a urinary tract infection (UTI) in a patient with a sulfonamide allergy, which commonly used UTI agent must be avoided?

Nitrofurantoin
Trimethoprim-sulfamethoxazole (TMP-SMX) (Correct answer)
Ciprofloxacin
Fosfomycin

Correct answer: Trimethoprim-sulfamethoxazole (TMP-SMX)

TMP-SMX contains sulfamethoxazole, a sulfonamide antibiotic, and must be avoided in patients with documented sulfonamide allergy.

Question 177: What is the standard of care requirement for pharmacology basics in clinical practice?

The minimum effort needed to avoid a lawsuit
The most aggressive treatment available
The level of care a reasonably competent practitioner would provide (Correct answer)
Whatever the practitioner feels is adequate

Correct answer: The level of care a reasonably competent practitioner would provide

The standard of care is defined as what a reasonably competent practitioner with similar training would provide under similar circumstances.

Question 178: Which evidence-based approach is most important when applying patient communication principles?

Relying solely on textbook guidelines from any era
Integrating current research with clinical expertise and patient values (Correct answer)
Following personal clinical intuition only
Using the most expensive available treatment

Correct answer: Integrating current research with clinical expertise and patient values

Evidence-based practice in ${subj.toLowerCase()} requires integrating current research findings with clinical expertise and individual patient values.

Question 179: A pharmacist reviews a patient's ECG and notes a prolonged QTc of 510 ms. Which drug interaction is most likely responsible?

Atorvastatin + amlodipine
Pantoprazole + metoprolol
Metformin + lisinopril
Azithromycin + haloperidol (Correct answer)

Correct answer: Azithromycin + haloperidol

Both azithromycin and haloperidol independently prolong the QTc interval, and their combination significantly increases the risk of torsades de pointes.

Question 180: A total parenteral nutrition (TPN) bag contains 500 mL of 50% dextrose and 500 mL of 10% amino acids. What is the final dextrose concentration in the combined 1000 mL solution?

20%
30%
60%
25% (Correct answer)

Correct answer: 25%

Dextrose content = 500 mL × 0.50 = 250 g; final concentration = 250 g ÷ 1000 mL = 0.25 = 25%.

Question 181: Which action BEST demonstrates culturally competent patient communication?

Treating all patients identically regardless of background
Using cultural stereotypes to predict patient needs
Avoiding discussion of cultural practices to prevent offence
Asking about cultural or religious practices that may affect medication use and adapting counselling accordingly (Correct answer)

Correct answer: Asking about cultural or religious practices that may affect medication use and adapting counselling accordingly

Culturally competent care involves actively exploring individual patient values and adapting communication to meet those needs.

Question 182: A 68-year-old patient with type 2 diabetes and CKD stage 3 (eGFR 35 mL/min/1.73m²) is poorly controlled on metformin 1000 mg BID. Which adjustment is most appropriate?

Increase metformin to 2000 mg BID
Reduce metformin to 500 mg BID and monitor renal function
Add sitagliptin without changing metformin
Discontinue metformin and initiate insulin (Correct answer)

Correct answer: Discontinue metformin and initiate insulin

Metformin is contraindicated when eGFR falls below 30 and should be used with caution below 45; at eGFR 35 with poor control, transitioning to insulin is the safest option.

Question 183: A pharmacist is preparing a compounded 0.5% betamethasone valerate in a pluronic lecithin organogel (PLO gel) base for transdermal delivery. The prescribing physician requests the preparation be formulated without preservatives. According to USP <795> and NAPRA compounding standards, what is the appropriate beyond-use date (BUD) for this preparation, and what additional testing consideration is uniquely triggered by the absence of a preservative?

BUD of 30 days at room temperature; no additional testing is required because PLO gel's lipophilic base inherently inhibits microbial growth
BUD of 90 days at room temperature; antimicrobial effectiveness testing (AET) is required before assigning a BUD beyond 30 days if no preservative is present (Correct answer)
BUD of 6 months refrigerated; preservative-free formulations are exempt from AET if the preparation is dispensed in a single-use container
BUD of 180 days at room temperature; the organogel base provides sufficient preservative activity through its poloxamer 407 content to satisfy USP <51> criteria

Correct answer: BUD of 90 days at room temperature; antimicrobial effectiveness testing (AET) is required before assigning a BUD beyond 30 days if no preservative is present

Under USP <795> (2023 revision) and NAPRA's Model Standards, non-sterile compounded preparations are categorized by compounding conditions. A Category 2 preparation (compounded for patient use in controlled conditions) without antimicrobial preservatives may be assigned a BUD of up to 90 days at room temperature — provided that stability data support this. Critically, when no preservative is intentionally added, USP <795> triggers a requirement for antimicrobial effectiveness testing (AET per USP <51>) if a BUD beyond 30 days is desired for water-containing or emulsion-type preparations. PLO gel contains water in its internal phase, making microbial contamination a real risk. The poloxamer 407 in PLO gel does not have intrinsic antimicrobial activity sufficient to meet USP <51> criteria — this is a common misconception. Single-use containers reduce contamination risk but do not exempt preparations from AET requirements.

Question 184: A 68-year-old patient with CKD stage 3b (eGFR 32 mL/min/1.73m²), type 2 diabetes, and heart failure with reduced ejection fraction (HFrEF, LVEF 35%) presents for medication review. Current medications include metformin 1000 mg BID, lisinopril 10 mg daily, and furosemide 40 mg daily. Which treatment plan adjustment is MOST appropriate?

Discontinue metformin; add insulin glargine; switch lisinopril to sacubitril/valsartan (Correct answer)
Discontinue metformin; add empagliflozin 10 mg daily and continue lisinopril
Continue all current medications; add carvedilol 3.125 mg BID
Reduce metformin to 500 mg BID; add dapagliflozin 10 mg daily

Correct answer: Discontinue metformin; add insulin glargine; switch lisinopril to sacubitril/valsartan

At eGFR <30, metformin is contraindicated (lactic acidosis risk) and SGLT2 inhibitors (empagliflozin, dapagliflozin) lose glycemic efficacy and are generally not recommended below eGFR 30-45 (depending on agent). For HFrEF, sacubitril/valsartan (ARNI) reduces mortality and is preferred over ACE inhibitors in stable patients — the PARADIGM-HF trial demonstrated superiority. Insulin is appropriate for glucose control at this eGFR. While a beta-blocker (carvedilol) is also indicated in HFrEF, option C addresses the more critical and immediate safety issue (stopping metformin) while optimizing HF pharmacotherapy.

Question 185: The ethical principle of justice in pharmacy practice primarily concerns:

Keeping patient information confidential
Telling the truth to patients
Distributing healthcare resources fairly and equitably (Correct answer)
Acting in the patient's best interest

Correct answer: Distributing healthcare resources fairly and equitably

Justice refers to fair distribution of benefits and burdens across patients and society, including equitable access to medications.

Question 186: A pharmacist receives a prescription for metformin 500 mg tablets with the sig 'i tab po BID ac'. What does 'ac' indicate?

Before meals (Correct answer)
At bedtime
After meals
With meals

Correct answer: Before meals

'ac' is the Latin abbreviation for 'ante cibum,' meaning before meals.

Question 187: In the context of Pharmacy Examining Board of Canada, what is the primary goal of medical ethics and law?

Provider convenience
Optimal patient outcomes and safety (Correct answer)
Cost reduction for the facility
Administrative efficiency

Correct answer: Optimal patient outcomes and safety

The primary goal of medical ethics and law in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 188: When assessing for signs of dehydration in a pediatric patient, which clinical sign is most reliable?

Capillary refill time greater than 2 seconds (Correct answer)
Body temperature above 38°C
Presence of mild periorbital edema
Heart rate below 60 bpm

Correct answer: Capillary refill time greater than 2 seconds

Prolonged capillary refill time (>2 seconds) is a reliable clinical indicator of dehydration and reduced peripheral perfusion in children.

Question 189: Two drugs act on the same receptor system. Drug A produces maximal efficacy equal to the endogenous agonist and has an EC50 of 2 nM. Drug B has an EC50 of 0.5 nM but achieves only 60% of the maximal response even at saturating concentrations. A patient receives both drugs simultaneously at concentrations that saturate their respective binding. What is the most accurate description of Drug B?

Drug B is a competitive antagonist that reduces the effect of Drug A
Drug B is a superagonist because its EC50 is lower than the endogenous agonist
Drug B is a full agonist with higher potency than Drug A
Drug B is a partial agonist with higher potency but lower intrinsic efficacy than Drug A (Correct answer)

Correct answer: Drug B is a partial agonist with higher potency but lower intrinsic efficacy than Drug A

Drug B has a lower EC50 (0.5 nM vs 2 nM), meaning it is more potent — it achieves half-maximal response at a lower concentration. However, even at saturating concentrations, it only reaches 60% of maximal efficacy, defining it as a partial agonist (lower intrinsic efficacy/Emax). Potency and efficacy are independent properties. A partial agonist, when occupying the receptor, can actually act as a functional antagonist against Drug A in the presence of both, but Drug B itself is not an antagonist — it does produce a response. A superagonist would exceed the endogenous agonist's Emax.

Question 190: What does 'chain of custody' documentation refer to in pharmacy practice?

The hierarchy of pharmacists supervising each other
Records showing how a medication was transferred, handled, and stored from manufacturer to patient (Correct answer)
Documents listing pharmacy ownership over multiple years
Certificates proving a pharmacist's license transfers between provinces

Correct answer: Records showing how a medication was transferred, handled, and stored from manufacturer to patient

Chain of custody documents the movement and handling of medications to ensure integrity, accountability, and traceability from origin to dispensing.

Question 191: In the context of Pharmacy Examining Board of Canada, what is the primary goal of patient communication?

Cost reduction for the facility
Optimal patient outcomes and safety (Correct answer)
Administrative efficiency
Provider convenience

Correct answer: Optimal patient outcomes and safety

The primary goal of patient communication in Pharmacy Examining Board of Canada is always to achieve optimal patient outcomes while maintaining safety standards.

Question 192: Which ethical principle is most directly applicable to documentation standards?

Maximize facility revenue
Beneficence — acting in the patient's best interest (Correct answer)
Follow the most convenient protocol
Prioritize speed over thoroughness

Correct answer: Beneficence — acting in the patient's best interest

Beneficence, the principle of acting in the patient's best interest, is fundamental to ethical practice in documentation standards.

Question 193: A pharmacy student (intern) under supervision makes an entry in a patient's profile. What additional documentation element is required?

Interns are not permitted to make any entries in patient profiles
The supervising pharmacist must re-enter all information personally
Both the intern's identifier and the supervising pharmacist's signature or co-sign are required (Correct answer)
Only the student's initials are needed with no supervision notation

Correct answer: Both the intern's identifier and the supervising pharmacist's signature or co-sign are required

Documentation by pharmacy interns requires co-signing by the supervising pharmacist to establish professional accountability and oversight.

Question 194: Which of the following is NOT a typical component reviewed in the PEBC credential assessment for internationally educated pharmacists?

Language proficiency test scores
Good standing certificate from home country pharmacy regulatory body
Educational transcripts and degree verification
Current malpractice insurance from home country (Correct answer)

Correct answer: Current malpractice insurance from home country

PEBC does not require home country malpractice insurance; however, educational transcripts, language proficiency, and a good standing certificate are typical requirements.

Question 195: A patient is picking up a narcotic prescription. What additional documentation is typically required compared to a regular prescription?

Patient ID verification, signature, and recording in a narcotic register (Correct answer)
Mandatory drug counselling documentation from a nurse
A physician's countersignature at the point of pickup
Only the standard prescription label

Correct answer: Patient ID verification, signature, and recording in a narcotic register

Narcotics and controlled substances require enhanced documentation including patient identification, signature collection, and entries in a controlled drug register.

Question 196: The PEBC Qualifying Examination Part I blueprint allocates competency domains across the exam. Which of the following MOST accurately reflects the approximate weighting of 'Patient Care' competencies relative to other competency domains?

All competency domains are weighted equally at approximately 25% each to ensure balanced coverage of the NAPRA framework
Patient Care competencies account for approximately 55% of the exam, with Drug Information and Dispensing comprising the other 45%
Patient Care competencies account for approximately 40% of the exam, with Professional Practice and Communication sharing the remaining 60% equally
Patient Care competencies account for approximately 70–75% of the exam, with the remaining domains covering Communication, Collaboration, and Systems (Correct answer)

Correct answer: Patient Care competencies account for approximately 70–75% of the exam, with the remaining domains covering Communication, Collaboration, and Systems

The PEBC QE Part I blueprint is heavily weighted toward Patient Care competencies (~70–75%), reflecting the primacy of direct patient care skills in pharmacy practice. The remaining domains — including Communication, Collaboration, Health Promotion, and System/Management — share the balance. This weighting is intentional and mirrors the Canadian Pharmacy Competencies framework, which emphasizes clinical decision-making above all other domains.

Question 197: A pharmacist is preparing a compounded sterile preparation (CSP) classified as Category 2 under USP <797>. The beyond-use date (BUD) assigned is 45 days refrigerated. Which of the following conditions MUST be met to support this BUD?

The preparation must be stored in a non-vented, light-resistant container
The pharmacist must have completed a minimum of 40 hours of sterile compounding training
The preparation must be prepared in an ISO 5 environment within a segregated compounding area (SCA)
The preparation must pass sterility testing and bacterial endotoxin testing (BET) before release (Correct answer)

Correct answer: The preparation must pass sterility testing and bacterial endotoxin testing (BET) before release

Under USP <797>, Category 2 CSPs that are assigned extended BUDs (beyond the default Category 1 limits of 12 hours at room temperature or 24 hours refrigerated) require sterility testing and bacterial endotoxin testing (BET) before patient administration. These tests are mandatory to justify the extended BUD assignment. Preparation in an ISO 5 environment is required for all sterile compounding but alone does not justify extended BUDs without testing.

Question 198: Which interpretation of a fasting plasma glucose (FPG) result would indicate prediabetes (impaired fasting glucose) according to Canadian guidelines?

FPG 5.6–6.9 mmol/L (Correct answer)
FPG ≥ 11.1 mmol/L with symptoms
FPG < 5.6 mmol/L
FPG ≥ 7.0 mmol/L on two occasions

Correct answer: FPG 5.6–6.9 mmol/L

A fasting plasma glucose of 6.1–6.9 mmol/L (per Diabetes Canada guidelines) indicates impaired fasting glucose (prediabetes).

Question 199: A candidate's PEBC Evaluating Examination Statement of Standing was issued 6 years ago, and they have not yet written the Qualifying Examinations. They now wish to proceed with the Qualifying Examination Part I. What is the MOST likely outcome of their application?

They are automatically advanced to Part II since sufficient time has elapsed
They must submit a written appeal to PEBC explaining the delay before their Statement of Standing can be reinstated
They must rewrite the Evaluating Examination because Statements of Standing expire after 5 years of inactivity (Correct answer)
Their Statement of Standing remains valid indefinitely and they may register for Part I without issue

Correct answer: They must rewrite the Evaluating Examination because Statements of Standing expire after 5 years of inactivity

PEBC Statements of Standing from the Evaluating Examination are not valid indefinitely. PEBC policy specifies that if a candidate does not proceed to the Qualifying Examinations within a set period (generally around 5 years), their Statement of Standing lapses and they must re-examine. A 6-year-old Statement of Standing would therefore typically require the candidate to retake the Evaluating Examination rather than simply re-registering for Part I.

Question 200: What does the Evaluating Exam assess?

Advanced clinical skills
Foundational knowledge of pharmacy (Correct answer)
Knowledge of Canadian law
Administrative abilities

Correct answer: Foundational knowledge of pharmacy

The Evaluating Exam, which is typically required for international pharmacy graduates, specifically assesses a candidate's foundational knowledge of pharmacy. This exam ensures that international applicants possess a baseline understanding of pharmaceutical sciences and practice principles comparable to Canadian-trained pharmacists. Passing this exam is a prerequisite for proceeding to the Qualifying Exam.

Question 201: A pharmacist is evaluating a randomized controlled trial (RCT) comparing a new antihypertensive to placebo. The study reports a relative risk reduction (RRR) of 40%, but the absolute risk reduction (ARR) is only 2%. Which statement best interprets these findings?

The RRR is more clinically meaningful because it accounts for baseline risk differences
The ARR is more clinically meaningful because it reflects the actual magnitude of benefit in the population studied (Correct answer)
Both values are equivalent measures of clinical significance
The RRR should always be used when counselling patients about treatment benefit

Correct answer: The ARR is more clinically meaningful because it reflects the actual magnitude of benefit in the population studied

The ARR (2%) reflects the true absolute difference in event rates between groups, giving the number needed to treat (NNT = 50). RRR can appear impressive even when baseline risk is low, making ARR and NNT the preferred measures of clinical significance.

Question 202: A Canadian pharmacy graduate preparing for the PEBC Qualifying Examination Part II (OSCE) reviews possible station formats. Which of the following station types is specifically INCLUDED in the PEBC OSCE and requires a written or typed response with NO live patient or standardized patient present?

Interdisciplinary case handoff station
Medication counseling station with a standardized patient
Drug information written-response station (Correct answer)
Structured history-taking station

Correct answer: Drug information written-response station

The PEBC OSCE Part II includes drug information written-response stations where the candidate reviews a scenario and must produce a written answer—no standardized patient is involved. This format assesses evidence retrieval, critical appraisal, and communication of drug information in writing. Candidates often over-prepare for interactive counseling stations and under-prepare for written stations, where time management and structured response format are critical differentiators.

PEBC Pharmacy Examining Board of Canada Exam

The Pharmacy Examining Board of Canada (PEBC) Qualifying Exam assesses entry-to-practice competencies for pharmacists including patient safety, clinical assessment, treatment planning, pharmacology, drug dispensing, compounding, pharmacy law, documentation, and patient communication.

200

Questions

240 min

Time Limit

65%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds